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ABSTRACT 
Oral cancer is the seventh most common cancer worldwide and its incidence is increasing. The 
most important risk factors for oral cancer are chronic alcohol consumption and tobacco 
smoking, up to 80 % of oral carcinomas are estimated to be caused by alcohol and tobacco. They 
both trigger an increased level of salivary acetaldehyde, during and after consumption, which is 
believed to lead to carcinogenesis.  
Acetaldehyde has multiple mutagenic features and it has recently been classified as a Group 1 
carcinogen for humans by the International Agency for Research on Cancer. Acetaldehyde is 
metabolized from ethanol by microbes of oral microbiota. Some oral microbes possess alcohol 
dehydrogenase enzyme (ADH) activity, which is the main enzyme in acetaldehyde production. 
Many microbes are also capable of acetaldehyde production via alcohol fermentation from 
glucose. However, metabolism of ethanol into acetaldehyde leads to production of high levels of 
this carcinogen.  Acetaldehyde is found in saliva during and after alcohol consumption. In fact, 
rather low ethanol concentrations (2-20mM) derived from blood to saliva are enough for 
microbial acetaldehyde production. The high acetaldehyde levels in saliva after alcohol challenge 
are explained by the lack of oral microbiota and mucosa to detoxify acetaldehyde by 
metabolizing it into acetate and acetyl coenzymeA. 
The aim of this thesis project was to specify the role of oral microbes in the in vitro production 
of acetaldehyde in the presence of ethanol. In addition, it was sought to establish whether 
microbial metabolism could also produce acetaldehyde from glucose. Furthermore, the potential 
of xylitol to inhibit ethanol metabolism and acetaldehyde production was explored. 
Isolates of oral microbes were used in the first three studies. Acetaldehyde production was 
analyzed after ethanol, glucose and fructose incubation with gas chromatography measurement. 
In studies I and III, the ADH enzyme activity of some microbes was measured by fluorescence. 
The effect of xylitol was analyzed by incubating microbes with ethanol and xylitol. The fourth 
study was made ex vivo and microbial samples obtained from different patient groups were 
analyzed. 
This work has demonstrated that isolates of oral microbiota are able to produce acetaldehyde in 
the presence of clinically relevant ethanol and glucose concentrations. Significant differences 
were found between microbial species and isolates from different patient groups. In particular, 
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the ability of candidal isolates from APECED patients to produce significantly more 
acetaldehyde in glucose incubation compared to healthy and cancer patient isolates is an 
interesting observation. Moreover, xylitol was found to reduce their acetaldehyde production 
significantly. Significant ADH enzyme activity was found in the analyzed high acetaldehyde 
producing streptococci and candida isolates. In addition, xylitol was found to reduce the ADH 
enzyme activity of C. albicans. Some results from the ex vivo study were controversial, since 
acetaldehyde production did not correlate as expected with the amount of microbes in the 
samples. Nevertheless, the samples isolated from patients did produce significant amounts of 
acetaldehyde with a clinically relevant ethanol concentration.  
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INTRODUCTION 
Oral cancer is the seventh most common cancer worldwide and has a poor prognosis, with a five 
year survival rate varying between 40-56%. The main risk factors are chronic alcohol 
consumption and tobacco smoking, in particular the conjoint use, which increases the relative 
risk for oral cancer multiplicatively. In developed countries, an estimated 75-80% of all oral 
cancers can be explained by the use of alcohol and tobacco. 
Ethanol itself is not a carcinogen, but its first metabolite, acetaldehyde, is. The International 
Agency for Research on Cancer has recently classified acetaldehyde, associated with alcohol 
consumption, to be a group 1 carcinogen for humans (Secretan et al. 2009). Acetaldehyde is 
capable of causing sister chromatid exchanges, point mutations, and interfering with the DNA-
repair system. It has also been reported that acetaldehyde forms DNA-adducts (Seitz and Stickel 
2009). 
Most acetaldehyde in the oral cavity is produced by some members of the oral microbiota. In 
studies where alcohol was consumed, salivary acetaldehyde levels were found to be markedly 
elevated (Homann et al. 1997). Acetaldehyde is produced mainly by the microbial alcohol 
dehydrogenase (ADH) enzyme. Alcohol is further rapidly metabolized in the liver into acetate by 
the low Km aldehyde dehydrogenase (ALDH2) enzyme. Aerobic bacteria that represent human 
colonic flora have a limited capacity to detoxify acetaldehyde (Nosova et al. 1996, Nosova et al. 
1998). This appears to be the case also with regard to oral microbiota (Salaspuro 2011). As 
mucosal cells lack low Km ALDH enzymes (Dong 1996), these conditions favor the 
accumulation of acetaldehyde in saliva during and after an alcohol challenge.  
APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy) is a rare 
autosomal disease that constitutes part of the Finnish Heritage of Diseases. It is caused by 
mutations in the AIRE gene. APECED patients have a markedly increased risk for oral cancer.  
In fact, over 10 % of adult patients with APECED in Finland have been diagnosed with oral 
cancer. The cancer has been found in the place of chronic candidosis which is one of most 
typical symptoms of the disease. Candidosis has been shown to be related to carcinomas but the 
mechanism is yet to be discovered. 
Most risk factors for oral cancer appear to be associated with an increased exposure of the oral 
cavity to acetaldehyde via saliva. The risk factors include alcohol, tobacco, poor oral hygiene, 
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and gene polymorphisms associating with enhanced acetaldehyde production from ethanol 
(Salaspuro 2003a, Salaspuro 2009a). Acetaldehyde exposure via saliva can, however, be 
markedly reduced. The number of oral microbes and acetaldehyde load from ethanol can be 
significantly decreased by using antimicrobial mouthwash containing chlorhexidine (Homann et 
al. 1997). Medical devices slowly releasing L-cysteine can be used for the binding and 
inactivation of acetaldehyde both in the mouth and achlorhydric stomach (Salaspuro et al. 2002, 
Salaspuro et al. 2006, Linderborg et al. 2010). Xylitol has been shown to have an 
“anticariogenic” impact and some inhibition in the metabolism of the S. mutans have been 
reported (Söderling 2009). However, the possible effects of xylitol on microbial acetaldehyde 
production are thus far unknown. 
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Review of the literature 
 
1. Oral Cancer 
 
Over 100 000 new oral cancers were diagnosed in Europe in 2006, making it the seventh most 
common cancer (3.2% of all cancers diagnosed) (Ferlay et al. 2007). The prevalence of oral 
cancer varies between different countries; in South-Central Asia, Melanesia and Central and 
Eastern Europe oral cancer is found more frequently (Jemal et al. 2011). The incidence for oral 
cancer in Europe is especially high in Hungary and France (La Vecchia et al. 1997). The 
worldwide incidence is increasing, only the incidence for lip cancer is decreasing (Scully 2011). 
  
Oral cavity squamous cell carcinoma (OSCC), originating from the oral keratinocyte, accounts 
for over 90% of all oral cancers. Other malignant lesions of the oral cavity include, for example, 
sarcomas, salivary gland malignancies, and metastases from other cancers (Baykul et al. 2010). 
OSCC continues to portend a poor prognosis, with an estimated 5-year overall survival rate of 
40-56% (Kademani et al. 2005, Scully and Bagan 2009). OSCC is typically found in the tongue, 
floor of the mouth, or gingivae (Silverman 2001), and is usually discovered as a red patch called 
erythroplakia, or white patch called leucoplakia, a nonhealing ulcerative lesion. In later stages, 
loosening of teeth, for example, may occur (Neville and Day 2002). Early OSCC manifestations 
are usually asymptomatic, but when the disease is in the advanced stage, the patients can suffer 
from pain, numbness, and additional difficulties in chewing, opening of the mouth, and 
swallowing. Sometimes an enlarged lymphatic node in the neck can be the first sign of the 
disease. Lymphovascular invasion typically takes place in the early stage of the disease and 
metastases can be found (Leon et al. 2000). A large primary tumor size is associated with 
increased cervical lymph node metastasis, increased risk of local recurrence, and poor survival 
(Woolgar 1999, Silverman 2001). The risk of developing a second OSCC primary tumor is 
relatively high (Silverman 2001). 
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1.1 Etiology of oral cancer 
Carcinogenesis requires a series of events where a normal cell transforms into potentially 
malignant cell. Mutagenic changes in the cellular DNA can occur spontaneously, or due to 
different substances such as alcohol, tobacco, and UV-radiation. The main risk factors for oral 
cancer are alcohol consumption and tobacco smoking (La Vecchia et al. 1997, Poschl and Seitz 
2004), which are estimated to cause 75-80% of all oral cancers (La Vecchia et al. 1997). Viral 
infections such as human papillomavirus (HPV), are sometimes able to cause mutagenic 
abnormalities as well. In addition, potentially malignant lesions, Betel, dietary factors, and poor 
dental hygiene, have been estimated to have a role in the etiology of oral cancer. A normal cell 
has many ways to protect itself from mutagenic changes, for example, the DNA repair system is 
able to correct changes in the DNA. In cases where correction fails, normal cells begin to 
apoptose, undergoing controlled cell death. Mutated cells may escape apoptosis, proliferate 
autonomously, and thus carcinoma can begin to grow (Scully 2011). Nevertheless, the host 
immune system should detect and destroy such abnormalities. Defects in the immune system, as 
seen in patients suffering from autoimmune polyendocrinopathy-candidiasis-ectodermal 
dystrophy (APECED), can predispose to carcinomas. 
 
1.1.1 Alcohol 
Alcohol consumption is one of the main risk factors for oral cancer (Seitz et al. 1998, Salaspuro 
2003b, Poschl and Seitz 2004, Boffetta and Hashibe 2006, Secretan et al. 2009), its effect is 
strongly dose-dependent (IARC 1986, IARC 1988, Pelucchi et al. 2008). Based on two meta-
analyses, the relative risk (RR) for oral and pharyngeal cancer is increasing rapidly with the 
concordant overall increase in alcohol consumption. Based on the results of Bagnardi et al’s 
meta-analysis, where 26 studies concerning oral and pharyngeal cancer were included, the RR 
for oral and pharyngeal cancer is increased to 1.75 when the daily use of ethanol is fairly low; 25 
g, which corresponds to approximately two doses of alcohol. With a daily intake of 50 g of 
ethanol, the RR is 2.85, and when the intake is increased to 100 g, the RR is 6.01 (Bagnardi et al. 
2001). In the meta-analysis by Zeka et al, the numbers are even higher; with daily ethanol dose 
of 0-48 g the RR is 1.5 and when the dose exceeds 48 g/day the RR is 7.2 (Zeka et al. 2003). 
These results are also confirmed by the latest meta-analysis (Tramacere et al. 2010). 
Ethanol itself as a molecule is not a carcinogen, but its first metabolite, acetaldehyde, is 
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(Homann et al. 1997, Salaspuro 2003a, Langevin et al. 2011, Joenje 2011). Acetaldehyde 
associated with alcohol consumption is regarded as 'carcinogenic to humans' (IARC Group 1) 
(Secretan et al. 2009). Upon consumption of alcohol, acetaldehyde is produced immediately by 
the microbes in the oral cavity (Salaspuro 1996, Homann et al. 1997, Väkeväinen et al. 2000, 
Salaspuro 2003a, Salaspuro 2003b, Linderborg et al. 2011). The microbial production of 
acetaldehyde may continue in the oral cavity four hours even after the end of alcohol 
consumption. This is due to the even distribution of ethanol to the whole water phase of the 
human body, including saliva (  Jones 1979, Jones 1983, Gubala and Zuba 2002).  
Certain alcohol beverages are believed to be more carcinogenic, such as calvados (Salaspuro 
2011). In the areas where calvados is being used such as southern France, oral cancer incidence 
is higher (La Vecchia et al. 1997, Scully and Bagan 2009, Launoy et al. 1997). Calvados 
contains much more acetaldehyde than many other commonly used alcoholic beverages 
(Linderborg et al. 2008). High acetaldehyde concentrations have also been found in fortified 
wines such as port wines and sherries (Lachenmeier and Sohnius 2008).  Very high acetaldehyde 
concentrations were recently reported to be in strong fruit spirits, which are used frequently in 
East European countries. This may explain the particularly high incidence of oral cancer in these 
countries (Boffetta et al. 2011). On the contrary, the lowest acetaldehyde concentrations are 
found in well distilled vodkas and beer (Lachenmeier and Sohnius 2008). 
A point mutation in ALDH2-gene provides strong evidence for the local carcinogenic action of 
acetaldehyde in the upper digestive tract via saliva. This gene mutation affects hundreds of 
millions of East Asians and results in decreased ALDH2 enzyme activity, in addition to 
decreased ability to detoxify acetaldehyde (Yokoyama et al. 2003).  Consequently, ALDH2 
deficiency results in markedly increased upper digestive tract cancer risk and elevated 
acetaldehyde levels in saliva after an alcohol challenge as will be discussed in subsequent 
chapters.  
1.1.2 Tobacco 
Tobacco smoking is an independent risk factor for oral cancer (IARC 1986). Warnakulasuriya et 
al. reviewed 11 different studies and calculated that the RR for upper digestive tract cancers in 
tobacco smokers varies between 1.6 and 20.7 (Warnakulasuriya et al. 2005). The amount of 
tobacco used has a strong impact on the RR. In a study by Moreno-Lopez et al., it is stated that 
when 1-20 cigarettes are smoked daily the RR for oral cancer is 3.15, but when more than 20 
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1.1.3 Ultraviolet radiation  
Ultraviolet radiation from the sun is a known risk factor for oral cancer, for lip cancer in 
particular. In a study by Kenborg et al., the OD for lip cancer was 1.67, if the patient had been 
working for more than 10 years outdoors (Gallagher and Lee 2006, Kenborg et al. 2010). Based 
on the review by Gallagher et al., there is sufficient evidence for a causal relationship between 
ultraviolet radiation from the sun and cancer of the lip. Radiation can cause mutations in DNA 
since it is able to enter the cell (Gallagher and Lee 2006).  
1.1.4 HPV 
Human papillomavirus (HPV) is reported to be the most important cause of cervical cancer and it 
has also been linked to oral cancer (zur Hausen 2009, Marur et al. 2010, Faridi et al. 2011). The 
role of HPV in cervical cancer is clear; more than 95% of biopsies from cervical cancer contain 
HPV (zur Hausen 2009). In oral cancer patients, the HPV prevalence has been 23.5% (Syrjänen 
2010). Zur Hausen estimates that 25-30% of oropharyngeal cancers could be induced by HPV 
(zur Hausen 2009). A strong association of HPV with potentially malignant oral lesions, such as 
oral lichen planus and oral leukoplakia, was shown in a recent review (Syrjänen et al. 2011). 
Viral infection caused by HPV can occur when the virus enters the host cell. HPV infection type 
16, in particular, can cause disruption in the host genome which might lead to mutagenic changes 
(Gillespie et al. 2009). The virus is able to inhibit the tumor suppressor p53 which enables the 
malignant growth of the tumor (zur Hausen 2002). HPV infection is most likely sexually 
transmitted and a wide number of sexual partners increases the odds for the infection (D'Souza et 
al. 2007). Nevertheless, controversial studies of the role of HPV in carcinogenesis are published. 
Based on a recent review, the role of HPV in oral cancer is not clear (Koshiol et al. 2010). The 
review concerns, however, only a Chinese population and it can be questioned, whether the 
results are consistent with other populations.  
1.1.5 Potentially malignant lesions 
Oral lichen planus (OLP) is a chronic systemic inflammatory disease caused by T-cell 
immunodysregulation (Al-Hashimi et al. 2007, Bidarra et al. 2008). Furthermore, Tao et al. 
showed that T regulatory cells (Treg cells) play a role in the pathology of OLP (Tao et al. 2010). 
Treg cells play a central role in maintaining immunologic tolerance to self and non-self, 
therefore changes in their action might expose patients to autoimmune diseases. The clinical 
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criteria for OLP issued by the World Health Organisation (WHO), indicates that mucosal lesions 
are usually bilateral, more or less symmetrical, and they contain different kinds of white lines 
(van der Meij and van der Waal 2003). Based on 26 different studies, the malignant 
transformation rate of oral lichen planus varies between 0.4% and 5.6% (van der Meij et al. 
2006). In another study, where 229 patients with OLP were followed up for four years, four of 
the patients were diagnosed with oral cancer which makes the risk for carcinoma approximately 
1.7% (Chainani-Wu et al. 2001). A review by Ramos-e-Silva et al., concludes that the possibility 
for OLP to develop into oral carcinoma is minor but exists clearly (Ramos-e-Silva et al. 2010). 
Oral lichenoid lesion (OLL) differs from OLP by its etiology though the clinical features 
resemble each other. OLP is typically bilateral unlike OLL. The etiology for OLL is believed to 
be type IV hypersensitivity reaction, for example allergy to dental filling material (Al-Hashimi et 
al. 2007, Muller 2011). 
Leucoplakia is a clinical term concerning a white patch in the oral mucosa that cannot be 
characterized histopathologically, or via any other means, as anything else (McCullough et al. 
2010, Kramer et al. 1978).  Leucoplakia can be, for example, hyperkeratosis, dysplasia, or 
caused by tobacco, and it can develop a papillary surface and a severe form that is proliferative 
verrucous leucoplakia (PVL). PVL can progress into a verrucous carcinoma (Neville and Day 
2002). Dysplastic changes can often be seen in leucoplakia and the risk for carcinoma is 
approximately 3.1% and equals that seen in lichen planus (Neville and Day 2002). Candida 
infection can be seen in leucoplakia, based on a study by Chiu et al., the recurrence rate of 
leucoplakia is increased in patients with candidosis (Chiu et al. 2011). 
In a study by Wang et al., it was suggested that some oral, potentially malignant lesions, become 
malignant due to deficiency in the DNA repair system (Wang et al. 2007). Further studies are 
still warranted in order to establish whether this hypothesis is a fact, but it may at least in part 
explain the faith of some potentially malignant lesions. 
1.1.6. Betel 
Smokeless tobacco has also been found to increase the risk of oral cancer, including the habit of 
betel quit chewing for instance, which is fairly common in some Asian countries such as India, 
Pakistan, Bangladesh, China, and Thailand (Reichart and Nguyen 2008). The International 
Agency for Research on Cancer states that betel quid chewing, with and without tobacco, as 
‘carcinogenic to humans (Group 1)’ (IARC 2004). The carcinogenic features caused by betel 
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quid chewing are possibly due to the areca nut which is the main component of betel quid. Areca 
nut contains arecoline which can induce mutagenic changes such as structural chromosomal 
aberrations and sister chromatid exchange (Chen et al. 2008). Nitrosamines derived from areca 
nut can also play a role in carcinogenesis (Zhang and Reichart 2007). 
1.1.7 Dietary factors 
Several epidemiological studies have been published on possible dietary correlates of oral cancer 
(La Vecchia et al. 1997, Riboli and Norat 2003, Pavia et al. 2006, Scully and Bagan 2009). 
Based on a recent review, the pooled RR for high vegetable consumption varies between 0.52 
and 0.65 meaning that the intake of vegetables may be protective to oral cancer (Lucenteforte et 
al. 2009). In contrast, the consumption of red meat and eggs has been related to increased oral 
cancer risk, although a consensus view has not been reached in the literature (Levi et al. 1998, 
Franceschi et al. 1999, Tavani et al. 2000, Lucenteforte et al. 2009). The etiological basis behind 
dietary factors remains unclear and it has been suggested that current dietary factors are related 
to the socioeconomical status of the patients that can be linked to oral cancer (Garavello et al. 
2008). 
1.1.8 Poor dental hygiene 
Poor dental hygiene has been associated with oral and esophageal cancer (Abnet et al. 2008). 
Based on two case-control studies made by Guha et al., the odds ratio (OD) for poor or average 
condition of the mouth and oral cancer was 4.51 (Guha et al. 2007). A larger amount of oral 
microbes (Abnet et al. 2005) and increased production of acetaldehyde from ethanol (Homann et 
al. 2001, Chocolatewala et al. 2010) have been suggested to contribute to the elevated cancer risk 
associated with poor dental hygiene. The role of microbes in the etiology of oral cancer has been 
pointed out as well in the review by Meurman (Meurman 2010). The author states that microbes 
may induce carcinomas due to ability to produce acetaldehyde but also for example due to act as 
tumor promoters. 
1.1.9 APECED 
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare 
autosomal disease caused by mutations of the autoimmune regulator (AIRE) gene (Heino et al. 
2001, Vogel et al. 2002, Mathis and Benoist 2007, Laakso et al. 2010). AIRE mutations mainly 
cause defects in T lymphocytes, which are central players in the immune system (Fierabracci 
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2011). Defects in the members of the Interleukin-family (IL) have also been found, such as the 
dysregulation of IL-7 (Laakso et al. 2011), that lead to autoimmune responses to various tissues, 
especially to endocrine glands. The most common features of the syndrome are chronic 
mucocutaneous candidosis, primary adrenocortical insuffiency and hypoparathyroidism. For a 
positive diagnosis, two of these are required (Husebye et al. 2009). The diagnosis can be hard to 
reach due to large variability of symptoms in patients. Other possible components are diabetes 
mellitus, gastrointestinal diseases, ectodermal dysplasia, keratoconjuctivitis, autoimmune 
hepatitis, vitiligo, alopecia, pernicious anemia, asplenia and dental, nail and tympanic membrane 
dystrophies (Perheentupa 2006, Husebye et al. 2009).  
The disease is rare outside of the populations of Finland, Sardinia and Iranian Jews (Husebye et 
al. 2009), and it is part of the Finnish Heritage of Disease (Norio 2003). Over 10 % of all 
APECED patients in Finland over the age of 25 are diagnosed with OSCC. The age of the 
patients at the time of diagnoses has been reported to be 29-44 years which is significantly lower 
than OSCC patients in general (Rautemaa et al. 2007). The etiology behind carcinomas remains 
unclear, however, carcinomas often develop in the areas of chronic mucositis which might partly 
explain the carcinogenesis. 
2. Oral microbiome 
2.1 General 
The oral microbiome is diverse and consists of a wide range of bacterial species, fungi, viruses, 
and sometimes even protozoa (Marsh and Martin 2005, Aas et al. 2005, Dewhirst et al. 2010). 
Over 750 different species have been identified by culture based methods and more are likely to 
be found. Up to 108 CFU/ml (colony forming unit/milliliter) bacteria can be found in saliva 
(Jenkinson 2005, Marsh and Martin 2009). The use of molecular methods has had an impact on 
our understanding of the oral microbiome (Dewhirst et al. 2010, Jenkinson and Lamont 2010). 
Pyrosequencing, in particular the use of PCR, has increased the resolution at which the 
microbiome can be analyzed (Keijser et al. 2008, Ghannoum et al. 2010, Jenkinson 2011).  
Oral microbes readily form a biofilm on oral surfaces such as teeth or mucosa (Avila et al. 2009, 
Jenkinson 2011). By forming this three-dimensional structure, microbes gain multiple properties, 
including an improved protection against host defenses and new invading microbes. Salivary 
proteins that bind onto tooth surfaces, and form a pellicle, enable microbial binding, the first step 
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of biofilm formation. Mainly gram-positive bacteria, such as some species of streptococci and 
actinomyces, are first adsorbed to the pellicle and begin to multiply (Marsh and Martin 2009, 
Jenkinson 2011). These are often referred to as pioneer species, which thereafter create 
conditions suitable for other microbes. Respiration reduces the oxygen tension and increases the 
level of carbon dioxide resulting in hypoxic conditions (Marsh et al. 2011) (Fig.2). Most oral 
micro-organisms are facultative anaerobes and thrive under these conditions. For example oral 
streptococci can survive deep in a biofilm. In addition, bacteria, fungi, and mycoplasmas can also 
be found in oral biofilms and they comprise the main part of the oral microbiome. In addition, 
protozoa such as trichomonas species have been found in salivary samples, which have been 
linked to defects in the host immune system (Martinez-Giron and van Woerden 2011). 
 
FIGURE 2. The metabolism of biofilm. In the deepest part of biofilms conditions are hypoxic. The metabolism 
of the pioneer species use nutrients and results in metabolic products. For example the concentration of potassium is 
higher and the concentration of sodium is lower within the biofilm compared to conditions at the surface.  The pH 
level also decreases as a result of metabolic activity.  
 
 
2.2 Bacteria 
Oral streptococci, found all parts of the oral cavity, form an essential part of the oral microflora. 
They comprise up to 50% of the total cultivable flora and 15% of the total oral microbiome 
(Jenkinson and Lamont 2005, Keijser et al. 2008). Oral streptococci and especially S. mutans are 
the primary pathogens causing dental caries. Other gram-positive cocci such as enterococci, 
staphylococci, and micrococci, can be found in low numbers from several oral sites. The latter 
two are often found in the nasal flora in addition to the oral cavity (Marsh and Martin 2009).
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Actinomyces and lactobacilli are the most commonly identified gram-positive rods in the oral 
cavity. Actinomyces species have been reported to be central in forming the dental biofilms and 
they comprise 8% of the dental plaque flora (Keijser et al. 2008). Lactobacilli are usually found 
in the oral cavity but they appear to comprise only 1% of the oral flora (Keijser et al. 2008).  
Neisseria gram-negative cocci species are the most commonly detected in the oral cavity and in 
dental biofilm. The relative amount of Neisseria species in saliva has been reported to equal that 
of actinomyces species (Keijser et al. 2008). Oral Neisseria are rarely associated with diseases 
(Marsh and Martin 2009).  Haemophilus and aggregatibacteria species are the most common 
gram-negative rods in the oral cavity. Haemophilus bacteria can be found in saliva, on epithelial 
surfaces, and in dental biofilm, contributing approximately 4% to the relative plaque amount 
(Keijser et al. 2008). Aggregatibacteria, especially A. actinomycetemcomitans has been 
associated with aggressive forms of periodontal diseases; their relative amount in a healthy oral 
microbiome is less than 1% (Keijser et al. 2008, Marsh and Martin 2009). 
Although many oral micro-organisms are facultative anaerobic, obligate anaerobic gram-
negative cocci and rods such as veillonella, eubacterium, prevotellae and fusobacterium spp. are 
commonly seen in the oral cavity as well. Veillonella, which comprises some 13% of plaque 
flora, can produce lactic acid and has been recognized to be one of the caries pathogens due to its 
ability to dissolve enamel (Marsh 1999, Keijser et al. 2008). Prevotella species are common 
especially in saliva; the relative amount is 20% (Keijser et al. 2008). Porphyromonas species and 
Treponema denticola have been linked to periodontal diseases and the relative amount of current 
bacteria increases in the absence of proper oral hygiene (Avila et al. 2009). Fusobacterium 
nucleatum has been shown to be able to invade epithelial cells. The bacterium also thrives in 
biofilms, the relative amount in plaque is 7% (Keijser et al. 2008, Avila et al. 2009) 
Mycoplasmas are pleomorphic micro-organisms that can also be isolated from the oral cavity. 
The outer membrane of mycoplasmas is not rigid and therefore they differ from other oral 
microbes (Marsh and Martin 2009). They can be considered to be surface parasites, typically 
isolated as Mycoplasma pneumonia, which can cause infection in the upper respiratory tract 
(Razin 1996). 
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2.3 Fungi 
Most of the fungi found in the oral cavity belong to the genus candida, although fungi of other 
genera such as aspergillus and saccharomyces can occasionally be seen (Marsh and Martin 2009, 
Ghannoum et al. 2010). Candida species are considered to be part of the oral microbiome and 
they can be found on any surface of the oral cavity. The most sensitive place for isolation of 
candida is the vestibular sulcus (Rautemaa et al. 2006). 
Candida can reside in the oral biofilms and the proportion of candida in biofilms can be 
especially high in patients with oral candidosis (Thein et al. 2006, Rautemaa and Ramage 2011). 
In healthy people, the oral carriage rate of Candida is 75 % (Ghannoum et al. 2010). Candida 
albicans is by far the most commonly isolated yeast in the oral cavity (Marsh and Martin 2009). 
Other clinically relevant candida species include C. tropicalis, C. krusei and C. glabrata which 
are often referred to as “non-Candida-albicans-species” (Marsh and Martin 2009, Nieminen et 
al. 2009). 
Oral candidosis is a superficial infection, which can be acute or chronic. Acute infection is 
usually caused by antimicrobial or local corticosteroid treatment, whilst chronic candidosis is 
more frequently seen in immunocompromised patients (Rautemaa and Ramage 2011). Chronic 
mucocutaneus candidosis is a rare form of the disease which has been diagnosed especially in 
APECED patients (Perheentupa 2002, Rautemaa and Ramage 2011). This form of candidosis has 
been linked to oral cancer (Rautemaa et al. 2007). 
 
2.4 Viruses 
Viruses differ in many ways from bacteria since they are not capable of reproducing themselves 
without the host cell. Viral infection initiates when virus enters the host cell and reacts with the 
cellular genome facilitating the commencement of Viral RNA and/or DNA production. Herpes 
simplex viruses, cytomegalovirus and human papillomavirus are the most commonly detected 
viruses in the oral cavity (Marsh and Martin 2009). 
Herpes simplex viruses type 1 and 2 are the most common viruses in the oral cavity. Type 1 is 
the most common and it is the primary causative agent of cold sores. The herpes infection is 
usually acquired in childhood (Arduino and Porter 2006), after which the virus can remain latent 
in the trigeminal nerve ganglion and cause symptoms occasionally. Cytomegalovirus is part of 
the herpes virus family and is often detected in the saliva, whereas human papillomaviruses 
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(HPV) can be found sometimes in the oral cavity. HPV has been connected to oral cancer, 
particularly HPV type 16 (Syrjänen 2010, Syrjänen et al. 2011, Termine et al. 2011).  
Human immunodeficiency virus (HIV) can also be detected in the oral cavity. The most common 
oral manifestations of HI-virus are candidiasis, oral hairy leukoplakia and acute or chronic 
ulcerative gingivitis (Gennaro et al. 2008). The severe forms of HIV in oral manifestations are 
Kaposi’s sarcoma (Leao et al. 2009) and lymphomas such as Non-Hodgkin’s lymphoma. 
Ebstein-Barr virus (EBV) has also been associated with the lymphomas in the oral cavity (Sarode 
et al. 2009). EBV can cause severe disorders in immunosuppressive patients, similar to HIV 
patients (Dojcinov et al. 2010). 
2.5 Energy metabolism of the oral microbes 
Carbohydrates are the main energy source for oral microbes. They all are able to metabolize 
carbohydrates such as glucose in order to form ATP (Flores et al. 2000, Marsh and Martin 2009, 
Petranovic et al. 2010, Zhang et al. 2010) (Fig 3.). In the metabolic route, glucose is converted to 
pyruvate by glycolysis. The fate of pyruvate depends on the oxygen tension and the microbe. In 
C. albicans, pyruvate is directly metabolized into Acetyl CoA by pyruvate dehydrogenase 
complex in aerobic conditions, but under hypoxia the anaerobic route activates (Askew et al. 
2009). In the latter reaction, acetaldehyde is formed. This formation of ethanol from glucose 
constitutes alcohol fermentation. In a recent study by Rozpedowska et al., it was shown that C. 
albicans is able to produce ethanol from glucose under anaerobic conditions, although the 
amount was found to be small (Rozpedowska et al. 2011). The authors stated that the metabolism 
of C. albicans prefers aerobic conditions. The atmosphere in the oral cavity is mostly 
microaerophilic and most likely both metabolic pathways are needed. Ethanol is toxic to 
microbes in high concentrations which could lead to metabolism avoiding ethanol accumulation. 
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Figure 3. The metabolism of glucose. Glucose is first metabolized into pyruvate in the reaction called glycolysis. 
The fate of pyruvate depends on the aerobic conditions. Both routes produce ATP but the end-products differ. 
 
 
 
3. Ethanol metabolism 
3.1 Distribution of ethanol 
Ethanol is a water soluble substance with a small molecular size. Due to these characteristics it is 
absorbed by simple diffusion from the intestine without a transport mechanism (Crabb et al. 
1987). The distribution of ethanol is equal for all of the body’s liquid compartments, which 
results in equal concentrations of ethanol in saliva and blood (Jones 1979, Gubala and Zuba 
2002).  
3.2 Ethanol and acetaldehyde metabolism  
The liver is the main site for ethanol metabolism in a healthy person (Seitz et al. 1994). Ethanol 
is metabolized via three pathways; by alcohol dehydrogenase enzyme (ADH), cytochrome P450 
2E1 (CYP2E1) and by catalase. Metabolism by catalase plays a minor role in ethanol 
metabolism, however ADH and CYP2E1 metabolic pathways are of principal interest (Seitz and 
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Stickel 2007). These two pathways catalyze the initial oxidation of ethanol into acetaldehyde. 
Acetaldehyde is further oxidized into acetate by aldehyde dehydrogenase enzymes (ALDH) (Fig 
4.). 
 
Figure 4. Ethanol metabolism in humans. Ethanol is metabolized into acetaldehyde and further into acetate by 
reversible reactions. 
 
 
The first reversible reaction where ethanol is oxidized into acetaldehyde via ADH is: 
CH3CH2OH + NAD ↔ CH3CHO + NADH + H. In this reaction acetaldehyde and a reduced 
form of nicotinamide adenine dinucleotide (NADH) are formed. When ethanol is metabolized 
into acetaldehyde via CYP2E1, the by-products of the reaction are reactive oxygen species 
(ROS).  
ADH and ALDH can be found not only in the liver but also in digestive tract cells. In a study 
performed by Dong et al., biopsies of gingival, lingual mucosa, and tongue were analyzed by 
their ADH and ALDH activity. Results were compared to the activities of stomach, esophagus, 
and colon. All biopsies investigated were found to possess ADH and ALHD activity, though the 
low Km ALDH activities of oral samples were found to be under the detection limit (Dong et al. 
1996). In a recent study by Koschier et al., a 3-D oral mucosal model, the 3-D EpiOral, was 
exposed to mouth washes containing alcohol. No acetaldehyde was found and the writers 
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therefore declare that oral mucosa does not possess ADH activity (Koschier et al. 2011).  The 
conclusions are controversial when compared to earlier literature (Moreno et al. 1994, Dong et 
al. 1996, Jelski et al. 2002, Seitz and Stickel 2007, Jelski and Szmitkowski 2008), which may be 
due to the fact that there were deficiencies in the study protocol. For example the artificial model 
lacks a connective tissue layer which is needed for the proper metabolic activity of oral mucosa 
(Lachenmaier and Salaspuro 2011).  
Microbes of the normal oral flora possess ADH activity and are responsible for the majority of 
acetaldehyde production in the oral cavity (Homann et al. 1997, Salaspuro 2003a, Salaspuro 
2009a, Seitz and Stickel 2007). 
 
3.3 Human ADH and ALDH enzymes 
Human ADHs have been grouped into five classes I – V by Jörnvall et al. (Jörnvall and Hoog 
1995). AHD I is named to be “the classical ADH” because it is responsible for the majority of 
enzymatic activity in the liver, but it can be found also in gastrointestinal tract, kidneys, and 
lungs (Jelski and Szmitkowski 2008). ADH I is composed of α-, β- and γ-subunits, which are 
encoded by ADH1A, ADH1B and ADH1C genes. Mutations in these alleles have been shown to 
be reflected in salivary acetaldehyde levels. Three different allelic forms of ADH1B have been 
found. ADH1B*2 allele results in approximately 40 times more active enzyme compared to 
enzyme encoded by ADH1B*1 allele. Two forms of ADH1C have been found. ADH1C*1 form 
leads to enzyme that is 2.5 times more active than ADH1C*2 (Bosron and Li 1986, Poschl and 
Seitz 2004, Jelski and Szmitkowski 2008). The ADH1B*2 allele is frequent in Asia and it has 
been announced to protect from alcoholism due to increased levels of acetaldehyde in blood after 
alcohol drinking. Increased blood levels of acetaldehyde can cause a flushing syndrome, which 
includes facial flushing, tachycardia, nausea, and even vomiting, after alcohol consumption 
(Enomoto et al. 1991, Higuchi et al. 1995, Seitz and Stickel 2007). 
ADH1C*1 allele results in increased levels of acetaldehyde in saliva after an ethanol challenge, 
which has been suggested to lead to increased risk for upper digestive tract cancer (Visapää et al. 
2004).  The epidemiological data of the increased cancer risk is, however, controversial (Coutelle 
et al. 1997, Sturgis et al. 2001, Poschl and Seitz 2004). The discrepancy has been explained by 
differences in the geographic distribution of ADH1C genotypes in Europe and by the fact that 
the negative studies have generally included controls with minor or moderate alcohol 
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consumption and the positive studies with alcoholics or heavy drinkers (Homann et al. 2006). 
Class II ADH has been found in liver, class III exists in all tissues, and class IV mainly in the 
gastrointestinal tract. ADH V is poorly known (Jelski and Szmitkowski 2008). 
Ten different human ALDH enzymes have been found. ALDH2 is responsible for most 
acetaldehyde oxidation (Seitz and Stickel 2007, Jelski and Szmitkowski 2008). The ALDH2 
enzyme has two allelic forms, the normal allele is named ALDH2*1 and the mutated form is 
known as ALDH2*2. The mutated form has a limited capacity to oxidize acetaldehyde into 
acetate, which results in increased acetaldehyde levels. Homozygous mutation of ALDH2*2 has 
been found to protect from alcoholism in the same way as ADH1B*2 (Higuchi et al. 1995).  A 
heterozygous form of ALDH2*2, instead, does not cause that severe flushing reaction, 
approximately 30-50% of the enzyme activity can still be reached (Poschl and Seitz 2004). Most 
importantly, ALDH2-deficiency results in elevated levels of acetaldehyde in saliva after alcohol 
challenge. After a moderate dose of alcohol, salivary acetaldehyde levels were found to be two to 
three times higher in patients with heterozygous mutant ALDH2*2 compared to patients with 
ALDH2*1 (Väkeväinen et al. 2000, Väkeväinen et al. 2001). These findings were confirmed by 
a Japanese group (Yokoyama et al. 2003).  
The association of ALDH2 deficiency with increased upper digestive tract cancer risk was 
discovered by Yokoyama et al., who reported that the heterozygous form of the current enzyme 
is connected to a strong incidence of upper digestive tract cancers among Japanese alcoholics 
(Yokoyama et al. 1996, Yokoyama et al. 1998). These findings have been later confirmed in 
multiple studies and meta-analyses (Brennan et al. 2004, Wu et al. 2005, Hashibe et al. 2006, 
Chen et al. 2006, Asakage et al. 2007, Lee et al. 2008, Guo et al. 2008, Gianfagna et al. 2008). 
 
3.4 Microbial metabolism of ethanol 
Several gastrointestinal tract microbes have been found to posses ADH-activity (Salaspuro 1996,  
Jokelainen et al. 1996, Jokelainen et al. 1996b, Nosova et al. 1997, Salaspuro et al. 1999, Muto et 
al. 2000, Salaspuro 2003a), as evidenced by strongly increased salivary acetaldehyde levels 
during and after ethanol consumption (Jokelainen et al. 1996a, Homann et al. 1997, Väkeväinen 
et al. 2000, Homann et al. 2000, Homann et al. 2001, Salaspuro 2003b, Linderborg et al. 2011) 
In the study by Väkeväinen et al., it was demonstrated that isolates of Neisseria in particular 
have high ADH activity and therefore the ability to produce acetaldehyde in ethanol incubation 
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was significantly higher than other isolates analyzed (Väkeväinen et al. 2001). This is in line 
with the study by Muto et al., where the ability of Neisseria to produce a significant amount of 
acetaldehyde in ethanol incubation was shown (Muto et al., 2000). Väkeväinen et al. also 
discovered that Streptococcus salivarius differs from other streptococci analyzed by its high 
ADH activity since other streptococci analyzed were found to have low ADH activity 
(Väkeväinen et al. 2001). 
Tillonen et al. showed that C. albicans strains isolated from the oral cavity are able to produce 
marked amounts of acetaldehyde from ethanol in vitro (Tillonen et al. 1999). Bertram et al 
reported that ADH1 is primary responsible for ethanol oxidation in C. albicans (Bertram et al. 
1996), but also ADH2 has been found (Jones et al. 2004). ADH1 has been shown to be a 
bidirectional enzyme being able to catalyse the metabolism of ethanol into acetaldehyde as well 
as of acetaldehyde into ethanol (Bertram et al. 1996). The expression of ADH in C. albicans has 
been shown to differ in different growth phases and the activity of ADH is increased especially 
in the exponential growth phase (Bertram et al. 1996). 
GI-tract microbes have also been found to possess some ALDH activity (Nosova et al. 1996, 
Nosova et al. 1998), but these were considerably lower than ADH activities. This might explain 
the accumulation of acetaldehyde both in the saliva and large intestine since ALDH is 
responsible for the reaction where acetaldehyde is further metabolized into acetate (Jokelainen et 
al. 1996, Jokelainen et al. 1996a, Salaspuro 2011).  
 
4. Acetaldehyde as a carcinogenic substance 
The International Agency for Research on Cancer (IARC) classified acetaldehyde recently as a 
group 1 carcinogen to humans (Secretan et al. 2009). Thus acetaldehyde included in beverages 
and formed endogenously during and after ethanol consumption is carcinogenic to humans 
(Salaspuro 2011). Acetaldehyde is a highly toxic, mutagenic, and carcinogenic substance that is 
able to facilitate the formation of DNA-adducts at a clinically relevant concentration (100 µM) 
(Theruvathu et al. 2005, Toh et al. 2010). These concentrations can be found in saliva after 
moderate ethanol consumption (Homann et al. 1997). Mutagenic 1,N2-propanodeoxyguanosine 
adducts are formed in dividing cells when acetaldehyde is converted into crotonaldehyde in 
dividing cells by polyamines (Theruvathu et al. 2005). Acetaldehyde can cause point mutations 
in lymphocytes, induce sister chromatid exchanges, and interfere with the DNA-repair machine 
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(Obe et al. 1986, Woutersen et al. 1986, Dellarco 1988, Espina et al. 1988). 
 The most convincing evidence for the carcinogenicity of acetaldehyde can be derived from the 
uniform epidemiological and biochemical data concerning ADLH2-deficient alcohol consumers 
who have markedly increased risk for upper digestive tract cancers and an elevated level of 
acetaldehyde in their saliva after ethanol consumption (Yokoyama et al. 1996, Yokoyama et al. 
1998, Väkeväinen et al. 2000, Väkeväinen et al. 2001, Yokoyama et al. 2003)  
 
5. Regulation of local acetaldehyde concentration 
The local acetaldehyde concentration in the mouth depends on many factors. Since the oral 
microbiome is the main causative agent producing acetaldehyde (Seitz and Stickel 2007,  
Salaspuro 2009a). One way to effect acetaldehyde production is to interfere with the oral 
microbiome, for example by reducing the amount of microbes which can be done by improving 
the oral hygiene (Homann et al. 2001). Xylitol is a sugar alcohol which has been shown to 
reduce the metabolism of certain oral microbes. Whether xylitol has an effect on acetaldehyde 
production will be discussed further. The oral mucosa may be responsible for acetaldehyde 
production to some extent due to its ADH enzymes (Seitz and Stickel 2007). Therefore 
mutations in the ADH enzyme have been shown to cause differences in salivary acetaldehyde 
levels (Visapää et al. 2004). A greater effect is associated with the mutation of ALDH2 enzyme 
because that is responsible for most of the metabolism of acetaldehyde to acetate (Väkeväinen et 
al. 2000, Seitz and Stickel 2007, Salaspuro 2009). Some oral microbes have been shown to have 
ADH activity (Tillonen et al. 1999, Muto et al. 2000) but the microbes seem to lack ALDH-
activity or the current enzyme activity is minor (Nosova et al. 1996, Nosova et al. 1998, 
Salaspuro 2011). Therefore, acetaldehyde accumulation is seen in the saliva during ethanol 
challenge (Homann et al 1997). In addition, acetaldehyde binding agents, such as L-Cysteine, 
can be used for the reduction of acetaldehyde exposure in the mouth (Salaspuro and Salaspuro 
2004). Naturally, the most effective way for the reduction of local acetaldehyde exposure via 
saliva can be achieved by avoiding alcohol and tobacco.  
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5.1 Chlorhexidine 
Chlorhexidine is an antimicrobial agent typically used in mouthwashes. It has been shown to 
reduce the total count of microbes in the oral cavity (Homann et al. 1997).  In the same study it 
was demonstrated that three days use of chlorhexidine mouthwash significantly decreases 
acetaldehyde production from ethanol in vivo (Fig. 5). The ability of chlorhexidine to decrease 
acetaldehyde production can be due to the effect of breaking the biofilm instead of reducing the 
total microbial count. Further studies are needed in order to establish why chlorhexidine reduces 
acetaldehyde production. 
 
Figure 5. The effect of chlorhexidine. Chlorhexidine (chx) significantly reduces microbial acetaldehyde 
production during ethanol challenge in vivo (Homann et al. 1997). (License to use the figure, number 
2731900176837) 
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5.2 L-Cysteine 
L-Cysteine is a semi-essential amino acid and a normal component of human diet. It can be 
synthesized from methionine and serine via transsulphuration. L-Cysteine reacts covalently with 
acetaldehyde forming 2-methylthiazolidine-4-carboxylic acid (Sprince et al. 1974, Salaspuro et 
al. 2002). In a study by Salaspuro et al., L-Cysteine reduced the acetaldehyde produced during 
ethanol challenge by 59 ± 8% (Salaspuro et al. 2002). In that experiment, L-Cysteine-lozenge 
slowly releasing L-Cysteine was fastened under the lip of volunteers before a moderate dose of 
ethanol followed by acetaldehyde analysis from salivary samples. As mentioned earlier, tobacco 
smoke contains acetaldehyde, which dissolves into saliva during smoking (Salaspuro and 
Salaspuro 2004).  L-Cysteine-lozenges containing only 5 mg of L-Cysteine are able to eliminate 
salivary acetaldehyde originated from tobacco smoking totally (Salaspuro et al. 2006).  
L-Cysteine can be used to eliminate acetaldehyde from achlorhydric stomach as well 
(Linderborg et al. 2010). Achlorhydria leads to achlorhydric atrophic gastritis that is the most 
important risk factor for gastric cancer (Sipponen et al. 1985, Aromaa et al. 1996, Salaspuro 
2011). In an achlorhydric stomach, oral microbes are able to survive and to produce acetaldehyde 
during an ethanol challenge (Väkeväinen et al. 2000, Väkeväinen et al. 2001). The many ways 
for the reduction of the local acetaldehyde exposure in the upper digestive tract provides new 
possibilities for future intervention studies (Salaspuro 2011). 
 
5.3 Xylitol 
Xylitol is a sugar alcohol used for example in chewing gums. Xylitol has been shown to prevent 
caries partly due to its ability to inhibit the metabolism and decrease the counts of S. mutans (Ly 
et al. 2006, Söderling et al. 2011). S. mutans incorporates xylitol as xylitol-5-phosphate, which is 
dephosphorylated, this “futile xylitol cycle” consumes energy and inhibits growth. Furthermore, 
xylitol-5-phosphate can inhibit glycolytic enzymes leading to reduced acid production (Söderling 
2009).  Xylitol also has an inhibitory effect against otopathogenic bacteria (Uhari et al. 2000).  
Xylitol can be formed from D-xylose which is a by-product of normal carbohydrate metabolism 
in yeasts. Xylitol is thereafter metabolized into D-xylulose (Fig.6). 
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Figure 6. Metabolism of xylitol. Xylitol is metabolized into D-xylulose by the enzyme XDH or into D-xylose by 
the xylose reductase. D-xylulose is further metabolized in the pentose phosphate pathway where the end-product is 
pyruvate. 
 
 
 
D-xylulose is further metabolized into xylulose-5-phosphate which enters to the pentose 
phosphate pathway. The end-product of this pathway is pyruvate (Iablochkova et al. 2003, Jin et 
al. 2005) (Fig 3.). Xylitol is metabolized into D-xylulose by xylitol dehydrogenase (XDH) which 
closely resembles ADH (Persson et al. 1993). As a matter of fact, XDH is part of the ADH 
enzyme family and the NAD-binding parts of the enzymes are similar (Kotter et al. 1990, 
Persson et al. 1993). The possible effect of xylitol to disturb ethanol metabolism is, however, not 
yet known.  
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AIMS OF THE STUDY 
The general aim of this study was to explore the ability of various members of the oral 
microbiome to produce acetaldehyde in the presence of clinically relevant ethanol and glucose 
concentrations. Furthermore the aim was also to find out whether by coincubating the isolates 
with xylitol the amount of acetaldehyde produced could be decreased. 
Specific aims were as follows: 
I. To measure the in vitro acetaldehyde production from ethanol by laboratory strains and 
clinical isolates of oral Streptococci. 
II. To compare the amount of acetaldehyde produced by Candida albicans isolates obtained 
from patients with APECED, or oral cancer, and healthy controls from ethanol and 
glucose in vitro. 
III. To examine the effect of xylitol, fructose and glucose on acetaldehyde production of 
Candida isolates from ethanol in vitro. 
IV. To compare the amount of acetaldehyde produced ex vivo from ethanol by cultured 
microbial samples from patients with cancer or lichen planus and healthy controls. 
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MATERIAL AND METHODS 
 
1. Material in the in vitro studies 
1.1 Microbial strains and isolates 
Altogether 94 laboratory strains and clinical isolates of microbes were used (Table 1). The 
laboratory strains were obtained from a culture collection (ATCC, American Type Culture 
Collection and CCUG, Culture Collection of University of Gothenburg) and external quality 
control specimens (UK NEQAS, United Kingdom National External Quality Assessment 
Service). Clinical isolates were isolated from patient samples by using conventional culture 
methods at the HUSLAB Laboratory of Clinical Microbiology of the Helsinki University Central 
Hospital (T-and HI-isolates), and Helsinki University Dental Institute (G- and L-isolates), and 
stored in the departmental depositories at -80°C. Identification was based on colony morphology, 
growth on chromogenic agar, microscopy, and biochemical reactions. 
For the experimental analysis, streptococci strains and isolates were incubated on Brucella agar 
plates (Becton Dickinson, Maryland, USA) in CO2-conditions for 48 h at 35°C (Alaluusua et al. 
1984). Colonies from pure cultures were suspended in phosphate buffered saline (PBS, 6 M) and 
optical density (od) at 492 nm was adjusted spectrophotometrically (Multiscan RC, Labsystems, 
Helsinki, Finland) to 0.1. This od corresponds to 1x108 colony forming units per millimetre 
(CFU/ml). Dilution plating was used to verify the microbial concentration. 
Candida strains and isolates were incubated on Sabouraud dextrose agar plates (Lab M, 
Lancashire, UK) in aerobic conditions for 48 h at 37°C. Colonies from pure cultures were 
suspended in phosphate buffered saline (PBS, 6 M) and optical density (od) at 492 nm was 
adjusted spectrophotometrically (Multiscan RC, Labsystems, Helsinki, Finland) between 0.3 and 
0.4. This od was found to correspond to 1x107 CFU/ml. Dilution plating was used to verify the 
microbial concentration. 
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Table 1. Strains and isolates used in the studies. 
Streptococcus 
strains and isolates 
Candida albicans 
isolates from 
healthy patients 
Candida albicans 
isolates from 
APECED 
patients 
Candida albicans 
isolates from oral 
cancer patients 
Non- Candida albicans-    
strains and isolates 
     
S. anginosus ATCC 33397 C. albicans HI-2501 C. albicans T-109 C. albicans T-1261 C. glabrata CCUG 32725 
S. anginosus T-40532 C. albicans HI-2521 C. albicans T-343 C. albicans T-1275 C. glabrata G212 
S. constellatus ATCC 27823 C. albicans HI-2530 C. albicans T-344 C. albicans T-1293 C. parapsilosis ATCC 22019 
S. constellatus T-42662 C. albicans HI-2535 C. albicans T-355 C. albicans T-1298 C. parapsilosis G170 
S. intermedius ATCC 27335 C. albicans HI-2543 C. albicans T-357 C. albicans T-1311 C. tropicalis ATCC 750 
S. intermedius T-41190 C. albicans HI-2564 C. albicans T-359 C. albicans T-1323 C. tropicalis G9 
S. mitis ATCC 33399 C. albicans HI-2579 C. albicans T-366 C. albicans T-1337 C. dubliniensis UK NEQAS 2/07 
S. mitis T-44744  C. albicans HI-2580  C. albicans T-370 C. albicans T-1345  C. dubliniensis G130  
S. mutans ATCC 27175 C. albicans HI-2656 C. albicans T-371 C. albicans T-1352 C. guillermondii UK NEQAS 9/ 06 
S. mutans L10 C. albicans HI-2659 C. albicans T-372 C. albicans T-1396 C. krusei ATCC 6258 
S. mutans L13 C. albicans HI-2677 C. albicans T-373 C. albicans T-1481 C. krusei T-880 
S. oralis ATCC 35037 C. albicans ATCC 90029 C. albicans T-375 C. albicans T-1505  
S. salivarius ATCC 13419  C. albicans T-376   
S. salivarius T-42104  C. albicans T-384   
S. sobrinus ATCC 33478  C. albicans T-391   
S. viridans T-47062  C. albicans T-392   
  C. albicans T-395   
  C. albicans T-436   
  C. albicans T-564   
  C. albicans T-695   
  C. albicans T-719   
  C. albicans T-816   
  C. albicans T-826   
  C. albicans T-916   
  C. albicans T-918   
  C. albicans T-923   
  C. albicans T-927   
  C. albicans T-931   
  C. albicans T-962   
  C. albicans T-967   
  C. albicans T-972   
  C. albicans T-975   
  C. albicans T-976   
  C. albicans T-926   
  C. albicans T-983   
  C. albicans T-985   
  C. albicans T-995   
  C. albicans T-1032   
  C. albicans T-1055   
  C. albicans T-1108   
  C. albicans T-1490   
  C. albicans T-1527   
  C. albicans T-1553   
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2. Material in the ex vivo study 
2.1 Subjects 
The study was a prospective, where three different groups of patients being treated at the 
Department of Oral and Maxillofacial Surgery, Helsinki University Central Hospital, or at the 
Helsinki University Dental Hospital, during 2007-2011 were enrolled; 30 patients diagnosed 
with oral cancer (OSCC), 24 patients diagnosed with oral lichen planus or lichenoid lesion 
(OLD), and 30 healthy control patients (CO) (Table 2.). The subjects had not received any 
antibiotics within 7 days and those with HIV or hepatitis virus infection were excluded. All 
participants signed an informed consent and completed a questionnaire regarding their oral 
health and hygiene, cigarette and alcohol consumption (Appendix 1.). 
 
2.2 Study design 
Microbial samples were taken from oral mucosa by using the filter paper method (Rusanen et al. 
2009). The lesion samples were taken from the site of active disease (OSCC/OLD) and control 
site samples from a contralateral site from healthy mucosa. After sampling the filter papers, 
diameter 13 mm, were immediately placed into sterile test tubes with 5 ml of sterile saline and 
processed within 60 min. For culture, the filter papers were agitated in saline for 30 s with five 3 
mm glass beads. Then, 100 μl of the suspension was cultured on selective and non-selective 
media under anaerobic and aerobic conditions. Fastidious anaerobe agar (FAA; Fastidious 
Anaerobe agar (LAB-M LAB 90) supplemented with 5% horse blood) was used to enumerate the 
total cultivable bacteria. Lysed blood agar (BA; Trypticase soy agar (BBL 211047) and Mueller 
Hinton agar (BBL 212257) supplemented with 5% horse blood) was used for enumeration of 
total aerobic bacteria. Neomycin-vancomycin blood agar (NV; blood agar and neomycin 
sulphate (Sigma N-1876) supplemented with vancomycin (7.5 μ/ml), menadion (0.5 μg/ml) and 
sheep blood 5 %) was used to enumerate anaerobic gram-negative bacteria. Cysteine, lactose-and 
electrolyte deficient agar (CLED; C.L.E.D medium (BBL 212218) was used to select aerobic 
gram-negative fermentative rods. To detect yeasts Sabouraud Dextrose agar (SP; Sabouraud 
Dextrose Agar (Lab M), Bacto Agar (Difco) supplemented with penicillin (100,000 IU/ml) and 
streptomycin) was used. The BA, CLED and SP plates were incubated at 37°C for 48 h and the 
FAA and NV plates were incubated under anaerobic conditions at 37°C for 7 days. After 
culturing the suspension, the filter paper was removed from the saline and placed onto an 
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additional FAA plate for 30 s, removed and streaked and incubated under anaerobic conditions. 
This plate was used for acetaldehyde analyses.  
After incubation, the number of bacteria and yeasts (CFU) and different bacterial colony 
morphology types were enumerated. The analyses were performed by two independent observers 
without knowledge of the sample type or interpretation by others. In cases of discrepancies, a 
consensus was reached by re-evaluation of the culture plates together. Gram stain was performed 
on all different colony morphology types from CLED and NV agars and the number of gram-
negative colonies was recorded. The ratio of gram-negative to gram-positive bacteria and the 
ratio of aerobic to anaerobic bacteria were determined. For acetaldehyde analysis, each side of 
the filter paper was placed onto FAA media for 30 s and the media was incubated in a similar 
manner. The suspension for acetaldehyde analysis was prepared using the second FAA plate by 
injecting 3 ml saline into the media and gently scrubbing the microbes. The suspension was 
thereafter transferred into the sterile test tube and closed tightly. 
 
Table 2. Patients of the fourth study. 
  Oral Cancer 
Oral Lichen 
Disease Control 
Total number 30 24 30 
Female:Male 12:18  16:8  19:11 
    
Smokers (%) 9 (32%) 4 (19%) 9 (31%) 
Alcohol consumers (%)* 24 (79%) 19 (91%) 
26 
(90%) 
Heavy drinkers (%)**  5 (17%) 1 ( 5%) 2 ( 6%) 
 
* excluding heavy drinkers 
**) exceeds WHO levels for harmful alcohol consumption (288g alcohol per week in men and 192g per week in women) 
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3. Methods 
3.1 Acetaldehyde measurement 
Microbial suspensions were transferred into a gas chromatograph vials. Thereafter, PBS-buffer 
containing ethanol, glucose, fructose or xylitol was added and the vial was immediately sealed. 
In the first study, two ethanol concentrations were used; 11 mM and 1100 mM. In the second 
study, 11 mM ethanol and 100 mM glucose was used. In the third study, 12 mM ethanol and 110 
mM fructose, glucose and xylitol were used. In the fourth study 22 mM ethanol was used. 
Samples were incubated for 30 min at 37°C in the studies 1-3 and 60 min in the fourth study. 
The reaction was thereafter stopped by injecting 50 µl of perchloric acid (PCA, 6 M) through the 
rubber septum of the test vial. Every sample was measured as a triplicate and the mean was used 
for the analysis. To measure the baseline and artefactual acetaldehyde, 50µl of PCA was 
immediately added to control vials and the suspension was equally incubated. The formed 
acetaldehyde was measured by headspace gas chromatography. The conditions for analysis were: 
Column 60/80 Carbopack B/5% Carbowax 20M, 2 m x 1/8” (Supelco Inc, Bellefonte, USA); 
oven temperature 85°C; transfer line and detector temperature 200°C; carrier gas flow rate (N2), 
20 ml/min (Jokelainen et al. 1994). 
 
3.2 ADH-analysis 
ADH-activity was measured by using fluorescence analysis with cofactor nicotinamide adenine 
dinucleotide (NAD) (Study I and III) and nicotinamide adenine dinucleotide phosphate (NADP) 
(Study I) (Holbrook et al. 1972). For the analyses, the microbes were first grown as described 
above. Streptococci cells were sonicated for 10 x 8s in an ice bath in the presence of a protease 
inhibitor cocktail (SIGMA, P 8340, Missouri, USA). Candida cells were lysed by glass bead 
vortexing in the presence of the same protease inhibitor cocktail. Five 1 min vortexing cycles and 
glass beads of 1.0 mm diameter were used. The samples were cooled on ice before each cycle.  
Cell lysates were centrifuged for 5 min at 2900 g (Hettich EBA 20, Germany), the supernatants 
were collected and further centrifuged at 139700 g for 65 min at 4°C (Beckman Optima LE-80k 
Ultracentrifuge, USA). This supernatant was collected and used for the analyses. Cytosolic ADH 
activity was determined by measuring the fluorescence (ex 340 nm, em 440 nm) after addition of 
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ethanol or ethanol and xylitol (final concentration 100 mM) and NAD (final concentration 2.5 
mM) at 25°C (study 1) and at 37°C (study 3 and 4) in 0.1 M glycine buffer (pH 9.6). Ethanol 
concentrations 0.68 to 2174 mM were used. ADH activity was determined by using Tecan 
SAFIRE monochromatorbased microplate detection system and Magellan Softwares V3.11 and 
V6.05 (Tecan Trading AG, Switzerland).To determine the enzyme activities the Lineweaver-
Burk plot was used. 
 
3.3 Statistical analysis 
Results are expressed as means (±SEM) of at least three replicate measurements. Statistical 
significance of the differences between the acetaldehyde production of microbial isolates were 
analyzed by Wilcoxon Signed Rank Test by SPSS 12.0 (Study I), differences between the patient 
groups by two-tailed Mann Whitney U-test by Graph Pad Prism version 5.00 (study II and IV), 
differences within patient groups by two-tailed paired t-test by Graph Pad Prism version 5.00 
(study II). The univariate analysis of variance was used for comparisons between species and 
experimental conditions. Spearman’s rho (rs) was used for the analysis of the correlations. The 
correlation was expressed with a 95% confidence interval and a P value. A P value less than 0.05 
were considered as statistically significant. The generalized estimating equations model was used 
for comparisons between species and experimental conditions in the third study (III). 
3.4 Ethical considerations 
In the study four (IV) where patients were involved, the study protocol was approved by the 
ethical committee of the Helsinki University Central Hospital (§ 47/2007, 25.4.2007, Dnro 
126/E6/07).  Informed consent was obtained from all subjects. 
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1.1.1 Acetaldehyde production by oral streptococci from ethanol 
The mean acetaldehyde produced from 11 mM ethanol was 19.4 µM (±5.0), and from 1100 mM 
ethanol 71.7 µM (± 15.04). Large variation and differences were found in the acetaldehyde 
production by analyzed streptococci isolates. Both isolates of Streptococcus mutans and the 
clinical isolate of S. mitis were not able to produce acetaldehyde in the incubation with 11 mM 
ethanol. Clinical isolate of S. salivarius was on the other hand able to produce mutagenic 
amounts of acetaldehyde in this ethanol concentration, 135.0 µM (±3.8 µM). Clinical isolate of 
S. salivarius was found to produce the significantly highest amount of acetaldehyde as well in 
the higher ethanol concentration; 426.3 µM (±12.6). 
 
1.1.2 Acetaldehyde production by candida isolates from ethanol 
The ability of Candida isolates to produce acetaldehyde from ethanol was analyzed in 11 mM 
incubation (Fig. 7). Large variation and differences were found in the acetaldehyde production 
by analyzed candida isolates. Both C. krusei isolates analyzed were found to be weak 
acetaldehyde producers; the average acetaldehyde produced being 53.7 µM (±9.1 µM). Of all 
isolates analyzed, C. glabrata was found to be able to produce the highest amount of 
acetaldehyde, 366.1 µM (±10.1 µM).   
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1.3 The effect of xylitol 
In the third study (III) the effect of xylitol was investigated by coincubating candida samples 
with xylitol and ethanol. Without xylitol, the mean acetaldehyde production within 30 minutes 
was 220 µM (±10.2), but when coincubated with xylitol, the mean acetaldehyde produced was 
only 32 µM (±1.7). The reduction of 84% was highly significant (p<0.0001) (Fig. 9). 
Acetaldehyde production was also analyzed in the absence of ethanol, but in this xylitol-
incubation only 1.8 µM (±0.3 µM) acetaldehyde was produced. 
 
Figure 9. The effect of glucose, fructose and xylitol on candidal acetaldehyde production in ethanol incubation. 
 
 
1.4 Microbial ADH-activity 
ADH-activity was measured in two studies (I and III). In the first study, ADH-activity was 
measured from four streptococci isolates; S. salivarius clinical isolate, S. intermedius clinical and 
laboratory isolates, and S. mitis laboratory isolate. The isolates were chosen due to their ability to 
produce a high amount of acetaldehyde compared to other analyzed streptococci. In the third 
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study, the ADH-activity of laboratory isolates of C. albicans, of C. glabrata and C. krusei was 
analyzed. The isolates were chosen because C. glabrata was found to be the highest 
acetaldehyde producer, C. krusei the lowest and C. albicans an average producer. Significant 
activity was measured in all analyzed streptococci, C. albicans and C. glabrata. ADH-activity of 
C. krusei was found to be low (Table 3.). 
 
Table 3. Km-values of microbial ADH-enzymes. 
Microbe Km-value (mM) Acetaldehyde produced in 11 
mM ethanol incubation (µM) 
S. salivarius T-42104 1.2 135.0 
S. intermedius T-
41190 
not calculable 58.0 
S. intermedius  
ATCC 27335 
1490.0 46.3 
S. mitis ATCC 33399 758.3 11.2 
C. albicans 
 ATCC 900029 
0.16 219.7 
C. glabrata  
CCUG 32725 
2.83 366.1 
C. krusei ATCC 6258 0.13 53.7 
 
The effect of xylitol on ADH-activity was measured with candida isolates. Xylitol was found to 
reduce the ADH-activity of C. glabrata by 61% when coincubated with 110 mM ethanol for 10 
minutes, and of C. albicans by 100%.  No effect was seen in C. krusei (Fig.10). 
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Figure 10.  ADH-activities of C. glabrata CCUG 32725 (A), C. albicans ATCC 90029 (B) and C. krusei ATCC 
6258 (C). Activities were measured by using fluorescence analysis with cofactor nicotinamide adenine dinucleotide 
(NAD) after addition of ethanol, or ethanol and xylitol. Xylitol reduced the ADH activity of the C. glabrata and C. 
albicans markedly.  
 
2. Results of the ex vivo study  
Microbes cultured from all samples were able to produce carcinogenic levels of acetaldehyde 
from ethanol but no significant differences between the patient groups were found (Fig.11). The 
amount of acetaldehyde produced did not correlate with the amount of microbes cultured from 
the samples. The cultured microbial samples differed significantly between patient groups when 
the colony forming units were compared. Oral cancer patients had significantly more microbes in 
their samples compared to other groups (Fig. 12). 
 
The number of aerobic bacteria was found to be significantly higher in OSC lesion sites 
compared to corresponding control sites (p=0.0003), both for sample sites of OLD patients 
(lesion p=0.0002, control p<0.0001) and control patients (p<0.0001). The number of anaerobic 
bacteria did not differ significantly between lesion and control sites in OSC patients. The 
difference was significant when the amount of anaerobes from the OSC lesion site was compared 
to both sample sites of OLD patients (lesion p=0.0007, control p<0.0001) and control patients 
(p<0.0001) The mean proportion of Gram-negative bacteria was found to be 8% of all bacteria in 
CO samples, 4% of the bacteria in OSCC lesions and 3% in OSCC control sites, 12% in OLD 
lesions, and 8% in OLD control sites. Thereafter it can be stated that the majority of bacteria 
were Gram-positive in all patient samples. 
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DISCUSSION 
Chronic alcohol consumption and tobacco smoking are generally accepted risk factors for oral 
cancer. They both result in increased salivary acetaldehyde level which has been concluded to be 
the main etiological reason behind upper digestive tract carcinogenesis (Salaspuro 2003a, Seitz 
and Homann 2007, Salaspuro 2009a, Seitz and Cho 2009, Seitz and Stickel 2009). Based on 
epidemiological, genetic, and biochemical evidence, acetaldehyde was recently declared to be a 
group 1 carcinogen for humans by the IARC (Secretan et al. 2009). All four studies included in 
this thesis showed that samples of oral microbiota are able to produce significant amounts of 
mutagenic acetaldehyde from clinically relevant ethanol concentrations. The phenomenon was 
detected both in vitro and ex vivo. The results support and expand the earlier literature on this 
topic (Jokelainen et al. 1996a, Muto et al. 2000, Väkeväinen et al. 2001, Väkeväinen et al. 2002, 
Salaspuro 2003a, Nieminen et al. 2009, Salaspuro 2009b). 
Carcinogenesis may take place when a cell is exposed to mutagenic substances numerous times.  
Various genetic abnormalities have been found in upper digestive tract cancers, such as 
activation of oncogenes and inactivation of tumor-suppressor genes (Toh et al. 2010). A normal 
cell is able to protect itself from carcinogens, for example by a DNA repair system which 
corrects the mutagenic changes that have occurred. DNA repair systems are able to remove the 
DNA adducts which can be induced by acetaldehyde (Wang et al. 2007), however, if the 
mutagenic substance damages the DNA repair system and the cell remains viable, carcinoma 
may start to develop. This has been shown to happen with acetaldehyde (Espina 1988). 
 
 
1. Acetaldehyde production by oral streptococci from ethanol 
Oral streptococci can be found from the oral microbiome in everyone (Jenkinson and Lamont 
2005, Keijser et al. 2008). Therefore the finding that some oral streptococci produce mutagenic 
amounts of acetaldehyde in clinically relevant ethanol concentrations may be important. Isolates 
of S. salivarius, in particular, appeared to be able to produce significant amounts of 
acetaldehyde. S. salivarius typically colonizes the mucosal surface of the oral cavity which is one 
of the sites where oral carcinomas can be found (Ruoff et al. 2003). 
The ethanol concentration in saliva is particularly high during alcohol consumption but it 
     
51 
 
decreases after the consumption to the same level as seen in the blood (Jones 1979). Therefore 
the aim here was to measure acetaldehyde production under these two ethanol concentrations, 11 
mM and 1100 mM. The smaller concentration reflects the one found in saliva in an average male 
after consuming 0.5 g ethanol per kg body weight. The latter concentration can be found in saliva 
immediately after a sip of an alcoholic beverage (Linderborg et al. 2011). 
In accordance with in vitro acetaldehyde production from ethanol, the clinical isolate of S. 
salivarius possessed significant ADH-activity. The Km of the enzyme was found to be relatively 
low (1.2 mM), which indicates that the enzyme is already activated in very low ethanol 
concentrations. Such low ethanol concentrations can be found even in certain foods and non-
alcoholic beverages which mean that acetaldehyde could be produced in the oral cavity even 
without drinking of official alcoholic beverages that contain over 2.8% of ethanol (Salaspuro 
2011). This was an in vitro study and pure cultures of planktonic streptococcal isolates were used 
which is a limitation, since oral microbes readily form biofilms in vivo.  Nevertheless, the results 
clearly show that certain isolates of this major group of oral microbes are able to produce 
acetaldehyde in clinically relevant conditions. 
2. Acetaldehyde production by candida from glucose, fructose and ethanol 
Chronic oral candidosis has been associated with carcinogenicity, especially in APECED 
patients (Rautemaa et al. 2007). Over 10% of the APECED patients over the age of 25 in Finland 
have been diagnosed with oral cancer at the site of candidal manifestation (Rautemaa et al. 
2007). In this thesis project (study II) the acetaldehyde production of C. albicans isolates from 
APECED patients was analyzed and demonstrated that in glucose incubation, the isolates 
produced significantly higher amounts of acetaldehyde compared to isolates from cancer and 
healthy patients. The produced mean level of acetaldehyde in glucose incubation in APECED 
patient isolates was nevertheless fairly low (53.5 µM) compared to the level of same isolates 
produced in ethanol incubation (247.9 µM). APECED patients develop oral cancer at relatively 
young age, the mean age at diagnosis being 37 years. This suggests that alcohol and tobacco 
cannot be the only etiological factors. The fact that candida isolates are able to also produce 
acetaldehyde from glucose could partly explain the carcinogenesis in APECED patients. 
On the other hand, many beverages and foodstuff contain minimal concentrations of ethanol and 
mutagenic concentrations of acetaldehyde. For example yogurts, kefir, some soya products, 
pickled vegetables, vinegars and even some fruits may contain marked amounts of acetaldehyde 
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(Salaspuro 2011, Uedelecker and Lachenmeier 2011, Lachenmeier 2011). Whether this has any 
relevance in carcinogenesis remains to be discovered, but it could partly explain the particularly 
high incidence of oral cancer especially in young APECED patients. 
All analyzed candida isolates produced acetaldehyde from ethanol in studies II and III. This 
confirms the earlier findings of Tillonen et al., whom reported that many Candida albicans 
isolates obtained from saliva samples are able to produce significant amounts of acetaldehyde 
(Tillonen et al. 1999). A new finding from this work was the large difference in the acetaldehyde 
production capacity between candida isolates.  C. krusei isolates were found to be low 
acetaldehyde producers and their ADH activity was also very low. On the other hand, C. 
glabrata isolates were found to produce six times higher levels of acetaldehyde as compared to 
C. krusei. When the acetaldehyde production was also analyzed from fructose, the mean 
acetaldehyde amount produced was found to be relatively low; 21.4 µM. The acetaldehyde 
production in ethanol-glucose and ethanol-fructose coincubations was found to be lower in the 
coincubations compared to incubation with ethanol. This might be due to a preference for sugars 
as an energy source over ethanol. The main energy sources for candida are carbohydrates such as 
glucose and fructose and especially in the aerobic atmosphere the metabolism prefers sugars.  
 
3. The effect of xylitol on microbial acetaldehyde production 
In the third study (III), it was discovered that xylitol strongly reduces the acetaldehyde 
production of different candida isolates in vitro. The mean reduction was 84%. Xylitol is used as 
a sweetener for example in chewing gums due to its “anticariogenic” features (Ly et al. 2006). 
Clinically relevant concentrations of both ethanol and xylitol were used in this study. The xylitol 
concentration used was equal to 17mg/ml, which can be found in the oral cavity during the 
chewing of xylitol-containing gums (Tapiainen et al. 2002, Lif Holgerson et al. 2006).  Xylitol 
also significantly reduced the ADH activity of C. albicans and C. glabrata isolates. The 
reduction is most likely due to the resemblance in the structure of the enzymes responsible for 
xylitol end ethanol metabolism, XDH and ADH. The NAD-binding parts of the enzymes are 
similar (Persson et al. 1993). In addition, the possible competition from NAD might lead to the 
downregulation of ADH. 
This was an in vitro study, thus similar to studies I and II, it is viable to question whether the 
laboratory circumstances correlate with the in vivo conditions in saliva. Oral microbes readily 
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form biofilms and the metabolism of microbes differs in the different parts of the biofilm, as do 
the oxygen tension and pH levels. The rinsing effect of saliva might have some impact as well. 
On the other hand, microbes in the oral cavity can be found in different metabolic phases. It has 
been discovered that candida which have been cultured for 16 hours are significantly more active 
in ethanol metabolism compared to the same isolates that have been cultured for 48 h (Marttila et 
al, unpublished data).  
 
4. Acetaldehyde production of microbes cultured from patient samples 
In the fourth study (IV), cultured microbial samples collected from patients with oral cancer, 
potentially malignant oral lesions, or healthy controls were used, and their capacity to produce 
acetaldehyde from ethanol in vitro was determined. The results were partly surprising; the total 
amount of microbes appeared not to correlate with the amount of acetaldehyde produced. No 
significant differences were found in the mean acetaldehyde production by the cultured microbial 
samples from three groups, though the number of colony forming units/microbial density varied 
significantly. On the other hand, all samples produced acetaldehyde under clinically relevant 
conditions. The ethanol concentration used in the incubation was 22 mM, which can be found in 
saliva of an average male after consumption of 0.7 g of ethanol per kg body weight. The method 
used is designed to sample microbes from oral mucosa quantitatively and qualitatively (Rusanen 
et al. 2009). 
Only cultivable microbes were analyzed in this study, as acetaldehyde measurements can only be 
performed on viable microbes. This may have altered the proportions between microbes due to 
different growth rates. As described earlier, the use of molecular techniques has had an impact 
on the understanding of oral microbiome, since not all oral microbes can be cultured. Whether 
the uncultivable microbes would have an effect on acetaldehyde production is yet to be 
discovered. On the other hand, the method is unique because for the first time, acetaldehyde was 
analyzed in a lesion and sampling area in a specific way. 
Mouthwashings of oral cancer patients have been found to produce more acetaldehyde than those 
of healthy controls (Jokelainen et al. 1996a). Ethanol concentration used was the same, 22 mM 
as well as the incubation time, 60 min. The difference might be due to different sampling 
methods used. Mouthwashing is not lesion specific and reflects planktonic microbes rather than 
those in biofilms. The clinical relevance of mucosa bound microbiome is that it could play a 
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more essential role in carcinogenesis than microbes in saliva. Furthermore, the patients in the 
study were found to have rather modest or poor dental hygiene. Poor dental hygiene correlates 
with increased acetaldehyde production in vitro in saliva samples (Homann et al. 2001). 
Nontheless, in our study no effect of poor dental status on the lesion-specific acetaldehyde 
production could be found. 
The aim of this study was also to find out if acetaldehyde production by the colonizing 
microbiome could explain the malignant potential of oral lichen planus and oral lichenoid lesions 
(OLD). No differences were found in the acetaldehyde production between healthy controls and 
OLD patients. In the review by Gorsky et al., it was concluded that the malignant transformation 
of OLD does not associate with consumption of alcohol or tobacco (Gorsky and Epstein 2011). 
This hypothesis is also supported by the findings of Wang et al., which showed that potentially 
malignant lesions progress into carcinomas due to defects in the DNA repair systems (Wang et 
al. 2007). If the repair system is damaged, DNA adducts are not removed and carcinogenes may 
begin. Therefore one explanation for the carcinomas in the OLD patients could be acetaldehyde 
induced DNA adducts.  
Another finding in this study was that the cultured microbial samples from smokers with oral 
cancer or lichen planus produced more acetaldehyde than samples from non-smokers. This is in 
accordance with earlier in vitro and in vivo findings showing that chronic smoking modifies oral 
flora to produce more acetaldehyde from ethanol (Salaspuro and Salaspuro 2004, Homann et al. 
2000). Tobacco smoke contains acetaldehyde and repeated exposure to it might lead to selection 
of microbes that are capable of high rate acetaldehyde metabolism and are more tolerant to 
acetaldehyde.  
 Study IV findings thus support the hypothesis that lifestyle habits such as tobacco smoking and 
alcohol consumption have a greater role in the carcinogenesis than the individual characters of 
the oral microbiome. As presented in the literature review, alcohol consumption and tobacco 
smoking are reported to explain up to 80% of oral carcinomas (La Vecchia et al. 1997). 
Therefore, it can be stated that our results are congruent with the literature. 
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SUMMARY AND CONCLUSIONS 
 
The main conclusions of this thesis are: 
I. We were able to show that some isolates of oral streptococci and almost all candida spp. 
produce significant amounts of acetaldehyde in clinically relevant ethanol concentrations 
in vitro. Streptococci form an essential part of the oral microbiome and candida can be 
found in the oral cavity from a majority of people. Therefore these microbes may be 
responsible for the majority of local acetaldehyde exposure in the oral cavity. 
Furthermore, our results confirm the earlier findings suggesting that microbial ADH 
enzyme associates strongly with the acetaldehyde production capacity of oral microbes. 
II. Candida isolates from APECED patients are able to produce significant amounts of 
acetaldehyde from glucose. APECED is a disease with exceptionally high risk for oral 
cancer. Candida isolates from APECED, oral cancer, and healthy patients were analyzed 
by their acetaldehyde production capability in ethanol and in glucose incubations. 
APECED isolates were able to produce higher amounts of acetaldehyde from glucose 
than the isolates from oral cancer and healthy patients.  
III. Xylitol significantly reduces in vitro acetaldehyde production from ethanol in the 
analyzed candida isolates. The reduction was as high as 84% and is most likely due to the 
inhibition of their ADH enzyme. In the analyzed C. albicans and C. glabrata isolates 
xylitol also reduced the ADH activity significantly. Candida isolates were found to 
produce significantly lesser amounts of acetaldehyde when incubated with glucose and 
fructose compared to the amounts produced in ethanol incubation. 
IV. Cultured microbial samples from oral cancer, OLD, and healthy control patients are able 
to produce significant amounts of acetaldehyde from ethanol in vitro but under the 
conditions used, no differences between the patient groups could be documented. The 
mean lesion specific acetaldehyde production was significantly higher than the minimum 
mutagenic amount of acetaldehyde. The findings support the concept that most oral 
cancers are more related to environmental factors, such as drinking and smoking habits, 
than to the individual characteristics of oral microbiota.  
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Appendix 1  
KYSELYLOMAKE  
Nimi:_______________________________________  
Koehenkilön ikä:____  
1. Miten usein olette käyttäneet alkoholia viimeksi kuluneen kuukauden aikana (ympyröi)?  
1. joka päivä  
2. Melkein joka päivä  
3. viikonloppuisin yhtenä päivänä  
4. viikonloppuisin kahtena päivänä  
5. viikonloppuisin kolmena päivänä  
6. 2-3 kertaa viikossa  
7. kerran viikossa  
8. 1-2 kertaa kuukaudessa  
9. harvemmin  
10. en lainkaan  
2. Paljonko joitte alkoholijuomia yleensä kerralla (ympyröi)?  
___1. 1-2 pullollista olutta/ long-drinkejä tai lasillisen viiniä  
tai 1-2 ravintola-annosta väkeviä = 22.5 g  
___ 2. 3-5 pullollista olutta/ long-drinkejä tai 5 lasillista  
viiniä tai 3-5 ravintola-annosta väkeviä = 60 g  
___ 3. 6-10 pullollista olutta/ long-drinkejä tai 1 ½ pullollista  
viiniä tai ½ pullollista väkeviä = 120 g  
___ 4. enemmän = 225 g  
3. Milloin olette viimeksi nauttineet alkoholia?  
4. Onko teillä jotain pysyvää lääkitystä?  
__ Ei  
__ Kyllä, mikä:____________________________________________________ 
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5. Nautitteko nyt tai oletteko viime kuukauden aikana nauttineet antibioottikuuria esim. 
hengitystieinfektioon, suolistosairauteen ym?  
__ En  
__ Kyllä, antibiootin nimi:___________________________________________  
6. Kuinka monta savuketta poltatte päivässä?  
____ 1. En tupakoi  
2. ___ savuketta päivässä.  
7. Kuinka kauan olette polttaneet?  
8. Onko teillä koskaan todettu suun hiivasieni-infektiota?  
1. Ei  
2. Kyllä, kerran  
3. Kyllä, useasti.  
9. Kuinka monta hammasta teillä on?  
10. Onko teillä hammasproteesia?  
1. Kyllä  
2. Ei  
11. Kuinka usein harjaatte hampaanne?  
1. harvemmin kuin kerran päivässä, kuinka usein?____________  
2. kerran päivässä  
3. kahdesti päivässä  
12. Milloin olette viimeksi syöneet/juoneet?  
13. Milloin olette viimeksi harjanneet hampaanne?  
14. Mitä käytätte suun puhdistukseen?  
1. Hammastahnaa  
2. Hammastikkuja/ -lankaa  
3. Suuvettä, mitä merkkiä?  
15. Käytättekö Xylitol-tuotteita? Milloin viimeksi?  
16. Onko jotain perussairauksia?  
Lisätietoja: 
I





Several studies have described the important role of mi-
crobes in the production of carcinogenic acetaldehyde to
the oral cavity. It has been demonstrated in vitro that in-
creased salivary acetaldehyde production is associated with
poor oral hygiene and with an increased number of bacteria
in saliva.22 Moreover, some oral Neisseria-strains have been
able to produce signiﬁcant amounts of acetaldehyde
in vitro.10 In vivo, patients with oral cancer have increased
number of bacteria of normal ﬂora such as oral streptococci
at their tumour sites. In addition, the tumour sites are fre-
quently colonized by Candida albicans-strains, which have
earlier been shown to be massive acetaldehyde produc-
ers.11,23 This local acetaldehyde production could be de-
creased with an antimicrobial chlorhexidine treatment,
which further highlights the important role of microbes in
acetaldehyde production in the mouth.3
There is strong evidence of the carcinogenicity of acetal-
dehyde. It causes point mutations in human lymphocytes, in-
duces sister chromatid exchanges and cross chromosomal
aberrations. Acetaldehyde even interferes with the DNA-re-
pair machine.24–26 Most recently, it was demonstrated that
polyamines are able to facilitate the formation of mutagenic
DNA-adducts in biologically relevant acetaldehyde concen-
trations (50–100 lM).4 The most convincing evidence for
the in vivo carcinogenic inﬂuence of acetaldehyde is derived
from epidemiological and biochemical studies on ALDH2-
deﬁcient Asians. Mitochondrial ALDH2-enzyme is responsible
for most of the acetaldehyde oxidation to acetate. Among
ALDH2-deﬁcient subjects this enzyme is partly inactive,
which results in the accumulation of acetaldehyde in saliva
after alcohol drinking.27 In Asian heavy drinkers ALDH2-deﬁ-
ciency associates with a 10-fold risk of oral cancer as com-
pared to those with the normal ALDH2-enzyme.28
The concentration of ethanol in saliva reﬂects directly
that of blood.29 Therefore, it is possible to detect ethanol
in saliva hours after drinking alcohol as salivary ethanol con-
centration decreases at the same speed as that in the blood.
During and immediately after drinking, ethanol concentra-
tion in saliva is temporarily much higher because ethanol
from alcoholic beverages dissolves directly to saliva. A con-
centration of 11 mM ethanol can be found in saliva of an
average male after drinking 0.5 g alcohol per kg body weight
and thus can be considered as clinically relevant. Therefore,
concentrations 11 mM and 1100 mM were used in the study.
As presented in the results, signiﬁcant acetaldehyde pro-
duction was detected at both ethanol concentrations.
Accordingly, acetaldehyde production by the oral strepto-
cocci is evident already at the beginning of alcohol drinking.
Similar results were obtained in a previous study where
some Neisseria-strains were investigated for their acetalde-
hyde production capacity.10
To our knowledge, this is the ﬁrst study where oral strep-
tococci, which comprise a major part of the normal oral
microﬂora,15 were tested systematically for their acetalde-
hyde production capacity. Signiﬁcant differences between
the strains regarding acetaldehyde production capability
and ADH-activity were detected. Based on our results it
could be stated that certain oral streptococci are able to
produce acetaldehyde in concentrations detectable also in
saliva samples in vivo during ethanol challenge. The marked
acetaldehyde producing capacity of the clinical strain of S.
salivarius is a particularly important ﬁnding as the bacte-
rium colonizes the mucosal surface of the oral cavity which
rarely is colonized by other normal ﬂoras bacteria. The
mucosal surface is the site where the oral cancer manifesta-
tions are frequently found.30 This bacterium had also an ex-
tremely high ADH-activity and low Km which indicates that
acetaldehyde may be produced in the oral cavity already
in very low alcohol concentrations.
Four of the tested streptococcus strains showed ADH-
activity. It remains to be examined, why some bacteria
were able to produce acetaldehyde, but did not possess
either NAD- or NADP-dependent ADH-activity. However,
other described metabolic pathways than the ADH-mediated
metabolism could account for the minor acetaldehyde pro-
duction observed in these strains.31 On the other hand, we
were able to show that several oral streptococci are able
to produce high amounts of acetaldehyde from ethanol in
saliva and that this production is dependent on the activity
and characteristics of ADH-enzyme of the bacteria.
In conclusion oral streptococci may contribute signiﬁ-
cantly to the normal individual variation of salivary acetal-
dehyde levels after alcohol drinking and thereby also to
the risk of oral cancer. As the in vitro measured acetalde-
hyde production has been shown to correlate with that
in vivo3 S. salivarius T-42104 could be considered as a harm-
ful bacterium in heavy drinkers. Further studies are never-
theless warranted in order to assess the possible role of
oral streptococci in the pathogenesis of oral cancer. The
most obvious approach in the future will be the measure-
ment of acetaldehyde production of microbial samples ob-
tained from patients with premalignant changes such as
oral leukoplakia and at the sites of diagnosed cancer.
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Chronic candidosis and oral cancer in APECED-patients: Production of carcinogenic acetaldehyde
from glucose and ethanol by Candida albicans
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Dear Sir,
Autoimmune polyendocrinopathy-candidiasis-ectodermal
dystrophy (APECED) is a rare autosomal recessive disease
caused by mutations of the AIRE (autoimmune regulator)
gene.1–3 It is associated with a limited T lymphocyte defect
and an autoimmune response to various tissues, particularly
endocrine glands. It mainly causes a set of three abnormal fea-
tures; chronic mucocutaneous candidosis, hypoparathyroidism
and adrenal insufﬁciency.4 Most patients have chronic oral
candidosis since early childhood. Of all the APECED patients
in Finland that are beyond the age of 25, 10% have developed
oral or oesophageal carcinoma at the site of chronic mucositis.5
It is the only malignancy diagnosed in these patients. The age
at cancer diagnosis was markedly low (29–44 years), signiﬁ-
cantly lower than for oral or oesophageal squamous cell carci-
noma in general. The pathogenetic mechanism behind
APECED associated oral cancer has so far remained unclear.6–9
The most important risk factors for upper digestive tract
cancers are tobacco smoking, alcohol intake, and poor oral
hygiene.10–12 They all associate with increased acetaldehyde
(ACH) levels in saliva, and there is strong evidence supporting
the role of ACH as a common dominator.13–18 The mechanism
leading to increased ACH levels in saliva after alcohol con-
sumption is local microbial ACH production, i.e. the oxidation
of salivary ethanol (EtOH) to ACH by microbial alcohol dehy-
drogenase (ADH)-enzyme.15–17 Previous studies have shown
that Candida albicans can produce signiﬁcant amounts of car-
cinogenic ACH in clinically relevant EtOH concentrations.19
It has been demonstrated that polyamines are able to facili-
tate the formation of mutagenic DNA-adducts in biologically
relevant ACH concentrations (50–100 lM).14 The local in vivo
carcinogenic effect of ACH is derived from epidemiological
and biochemical studies on aldehyde dehydrogenase-2
(ALDH2)-deﬁcient Asians. The mitochondrial ALDH2-
enzyme is responsible for most of the ACH oxidation to ace-
tate. Among ALDH2-deﬁcient subjects this enzyme is partly
inactive, which results in the accumulation of ACH in saliva
after alcohol drinking.20 In Asian heavy drinkers ALDH2-deﬁ-
ciency is associated with a 10-fold risk of oral cancer when
compared to those with the normal ALDH2-enzyme.21 How-
ever, the relationship between glucose and ACH production by
Candida albicans has not been investigated previously. C.
albicans may play a role in metabolizing glucose into carcino-
genic ACH in the mouth and could participate in the pathoge-
nesis of oral cancer in non-alcohol drinkers. The aim of this
study was to compare the production of ACH from EtOH and
glucose by oral candida isolates from APECED patients with
control isolates.
A total of 67 clinical oral isolates and one reference strain
(ATCC 90029) of Candida albicans were selected for this
study. Of these, 44 were isolated from 21 APECED patients
during the years 1994–2007 (1–4 isolates/patients) mainly as
reported earlier.22 Twelve isolates from patients with oral car-
cinoma were designated as cancer-isolates and 11 isolates
obtained from patients with oral candidosis but without any
mucosal neoplasia were designated as control-isolates. The C.
albicans isolates were identiﬁed from patient samples using
conventional culture and identiﬁcation methods at the Clinical
Microbiology Laboratory of the Helsinki University Central
Hospital. The identiﬁcation of C. albicans was based on colony
morphology on CHROMagar1 Candida medium (CHRO-
Magar, Paris, France), and the negative Bichro-Dubli1 latex
co-agglutination test result (Fumouze Diagnostics, Levallois
Perret, France). C. albicans strains were subcultured on Sabo-
uraud Dextrose agar (SP; Saboraud Dextrose Agar (Lab M),
Bacto Agar (Difco) supplemented with penicillin (100 000 ui/
ml) and streptomycin) for 48 hr at 35C. Colonies were sus-
pended in phosphate buffered saline (PBS) and adjusted to an
optical density (OD) of 0.4 at 492 nm (Multiscan RC spectro-
photometer, Labsystems, Helsinki, Finland) corresponding to
1 3 107 colony forming units per millilitre (CFU/ml) as con-
trolled by dilution plating.
A total of 400 ll of the yeast suspension was transferred
into a gas chromatograph vial. Thereafter, 50 ll of PBS-buffer
containing EtOH or glucose was added and the vial was imme-
diately closed tightly. The ﬁnal EtOH concentration was
adjusted to 11 mM and the ﬁnal glucose concentration to
100 mM. Samples were incubated for 30 min at 37C, and the
reaction was stopped by injecting 50 ll of perchloric acid
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(PCA, 6M) through the rubber septum of the test vial. Every
isolate was assayed in triplicate and the mean was used for
the analyses. To measure the baseline and artefactual ACH,
50 ll of PCA was immediately added to control vials and the
suspension was equally incubated for 30 min at 37C. The
formed ACH was measured by gas chromatography as
reported earlier.23
Results are presented as mean 6 standard error of mean
(SEM). Data was analyzed by using Graph Pad Prism version
5.00 (GraphPad Inc. San Diego, California, USA). The two-
tailed Mann Whitney U-test was used for the comparisons
between the patient groups. The two-tailed paired t-test was
used for the comparisons within patient groups. p values of
less than 0.05 were considered statistically signiﬁcant.
When incubated in glucose the mean ACH production by the
44 C. albicans isolates from APECED patients was 53.5 lM
(62.3 lM). The means for the cancer and control isolates were
33.7 lM (63.5 lM) and 34.6 lM (61.9 lM), respectively
(Fig. 1a). The APECED isolates produced signiﬁcantly higher
amounts of ACH than the cancer isolates (p < 0.0001) and the
control isolates (p < 0.0001). The differences between the can-
cer and the control isolates were not signiﬁcant. The mean
ACH production by the reference strain of C. albicans ATCC
90029 was 38.02 lM6 2.06 lM in glucose incubation.
When incubated in EtOH the mean ACH production of the
APECED isolates was 247.9 lM (64.2 lM). The means for
the cancer and control isolates were 280.2 lM (611.8 lM)
and 299.1 lM (612.7 lM) (Fig. 1b). The cancer and control
isolates produced signiﬁcantly higher amounts of ACH from
EtOH than APECED isolates (p 5 0.0072 and p 5 0.0003,
accordingly). The differences between the cancer and the
control isolates were not signiﬁcant. The mean ACH produc-
tion by the reference strain of C. albicans ATCC 90029 was
157.43 lM (61.57 lM) in EtOH incubation. All C. albicans
isolates produced signiﬁcantly more ACH in EtOH than glu-
cose incubation (p5 <0.0001).
From 14 APECED patients multiple isolates (2–4 per
patient) from years apart were tested. There was no signiﬁcant
difference in the ACH production from EtOH or glucose
between the earlier and more recent isolates from 6 patients.
There were some differences between the earlier and more
recent isolates from 8 patients, mostly when incubated in glu-
cose, but there was no obvious temporal trend nor were the dif-
ferences signiﬁcant.
In this study we were able to show that C. albicans isolated
from APECED patients produced potentially mutagenic
amounts of ACH when incubated in 100 mM glucose. The
amount of ACH produced was signiﬁcantly higher when com-
pared to C. albicans strains isolated from groups of patients
with oral cancer or from healthy controls. 100 mM glucose is
equivalent to 18 g/L, which can commonly be found in food
and drinks.24 Consumption of sweeter products may lead to
even higher ACH levels and prolonged exposure. 100 mM glu-
cose has also been shown to increase bioﬁlm formation and ad-
hesion of C. albicans in the oral cavity that may enhance the
local mucosal exposure to ACH.24,25
The mean age at diagnosis of oral cancer in Finland is over
60 years and oral cancer is very uncommon among healthy
young adults.26 In APECED patients, however, the mean age
at diagnosis is only 37 years.5 The early onset of oral cancer in
APECED patients could be partially due to their immune
defect and other intrinsic factors. However, both extrinsic and
intrinsic factors may operate, and with many of the factors,
only long exposure might be carcinogenic. Most APECED
patients suffer from refractory oral candidosis since early
childhood and the oral carcinoma typically develops at the site
of chronic mucositis. This supports the role of C. albicans in
the pathogenesis of the carcinoma.5
According to our results all C. albicans isolates analysed
were capable of producing carcinogenic levels of ACH from
EtOH. The isolates from cancer and control subjects produced
signiﬁcantly higher amounts of ACH than those from
APECED patients but the clinical relevance of this difference
is questionable since all isolates produced very high amounts.
The 11 mM EtOH concentration used can be found in saliva
for hours after social alcohol consumption or naturally in many
products produced by fermentation.17
The main ﬁnding of this study is that C. albicans may play a
role in metabolizing glucose to carcinogenic ACH in the
mouth and could participate in the pathogenesis of oral cancer
in non-alcohol drinkers. The observation supports the concept
of a novel microbially mediated mechanism in the pathogene-
FIGURE 1 – The acetaldehyde production of Candida albicans isolated from APECED (n 5 44), cancer (n 5 12) and control patients (n 5
11) in glucose (a) and ethanol (b) incubation. Mean (1SEM) lM of each group presented. When incubated in 100 mM glucose (a) the APECED
isolates produced signiﬁcantly higher amounts of acetaldehyde than the cancer isolates (p < 0.0001) and the control isolates (p < 0.0001).
When incubated in 11 mM ethanol (b) the cancer and control isolates produced signiﬁcantly higher amounts of ACH from ethanol than
APECED isolates (p 5 0.0072 and p 5 0.0003, accordingly). The differences between the cancer and the control isolates were not signiﬁcant.
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sis of oral cancer and could partly explain why chronic oral
candidosis is carcinogenic in APECED patients and why they
have a high risk for oral cancer at an early age.
Yours sincerely,
Johanna UITTAMO*, Emilia SIIKALA, Pertti KAIHOVAARA,
Mikko SALASPURO and Riina RAUTEMAA
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Acetaldehyde is a highly toxic and mutagenic product of alcohol fermentation and metabolism which has been classified as a
Class I carcinogen for humans by the International Agency for Research on Cancer of the World Health Organisation (WHO).
Many Candida species representing oral microbiota have been shown to be capable of marked acetaldehyde production. The
aim of our study was to examine the effects of various sugar alcohols and sugars on microbial acetaldehyde production. The
study hypothesis was that xylitol could reduce the amount of acetaldehyde produced by Candida. Laboratory and clinical
isolates of seven Candida species were selected for the study. The isolates were incubated in 12 mM ethanol and 110 mM
glucose, fructose or xylitol at 37C for 30 min and the formed acetaldehyde was measured by gas chromatography. Xylitol
significantly (p < 0.0001) reduced the amount of acetaldehyde produced from ethanol by 84%. In the absence of xylitol, the
mean acetaldehyde production in ethanol incubation was 220.5 lM and in ethanol–xylitol incubation 32.8 lM. This was found
to be mediated by inhibition of the alcohol dehydrogenase enzyme activity. Coincubation with glucose reduced the amount of
produced acetaldehyde by 23% and coincubation with fructose by 29%. At concentrations that are representative of those
found in the oral cavity during the intake of proprietary xylitol products, xylitol was found to reduce the production of
carcinogenic acetaldehyde from ethanol by Candida below the mutagenic level of 40–100 lM.
Acetaldehyde is a highly toxic and mutagenic product of
alcohol fermentation and metabolism. Recently, acetaldehyde
was reclassiﬁed as a Class I carcinogen for humans by the
International Agency for Research on Cancer of WHO.1
Mutagenicity can take place at concentrations as low as 40–
100 lM of acetaldehyde.2 Microbes possessing alcohol
dehydrogenase (ADH) activity can produce acetaldehyde by
ethanol oxidation.3 This reaction takes place in the oral cavity
when consuming alcohol and it continues for as long as there
is ethanol in saliva.4 Due to the equal distribution of ethanol
to the ﬂuid compartments of the body its concentration in
saliva is the same as in the blood and its clearance is nonlin-
ear in both.5 Streptococcus viridans and Neisseria group
bacteria belonging to the core oral microbiota have been
shown to be able to produce signiﬁcant amounts of acetalde-
hyde from ethanol.6,7 Furthermore, many Candida species
representing the normal oral ﬂora of the vast majority of the
population have been shown to be capable of even more
marked acetaldehyde production.8–10 Microbial acetaldehyde
production is one of the key mechanisms in the cumulative
exposure to carcinogenic acetaldehyde.11
Candida species can produce signiﬁcant amounts of
acetaldehyde also by alcohol fermentation from glucose.9,12
Glucose is ﬁrst metabolized via this pathway into pyruvate
and thereafter into acetaldehyde and ethanol. Fructose can
similarly be metabolized into pyruvate or alternatively to
glycerol. Glucose together with fructose constitutes the
dietary disaccharide sucrose. Xylitol is a ﬁve-carbon nonfer-
mentable sugar alcohol which is metabolized into D-xylulose
by xylitol dehydrogenase (XDH) closely resembling ADH.13
Sugars are the main carbon and energy source for yeast cells
but they can also use alternative nutrient sources such as
amino acids and proteins. Different nutrients run through
multiple metabolic pathways whose enzyme activities are
regulated mainly by availability of oxygen and cellular coen-
zyme balance.
It has been suggested that chlorhexidine oral rinses
could be used in controlling microbial acetaldehyde produc-
tion in the oral cavity.4 Chlorhexidine is a broad spectrum
Key words: acetaldehyde, xylitol, Candida, cancer
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or as individual data points and means. The generalized esti-
mating equations model was used for comparisons between
species and experimental conditions. Replicate values for each
isolate formed the subgroups in this model. Spearman’s rho
(rs) with a 95% conﬁdence interval and the means of replicate
values were used for the analyses of correlations. A p value
less than 0.05 were considered as statistically signiﬁcant.
Results
All Candida isolates were able to produce signiﬁcant amounts
of acetaldehyde. The mean acetaldehyde production in etha-
nol incubation at 30 min was 220.5 lM (610.2) (Fig. 1).
Xylitol coincubation reduced the amount of acetaldehyde
produced by a mean of 84%. This was statistically highly sig-
niﬁcant (p < 0.0001). The mean acetaldehyde production in
ethanol–xylitol incubation was 32.8 lM (61.7). When the
isolates were coincubated with glucose or fructose a less
marked reduction was observed (Fig. 1). Coincubation with
glucose reduced the amount of produced acetaldehyde by
mean 23% and coincubation with fructose by mean 29% when
compared to incubation with ethanol alone (p ¼ NS). The
mean acetaldehyde production in ethanol–glucose incubation
was 170.4 lM (611.3) and in ethanol–fructose incubation,
158.5 lM (610.3). None of the isolates were able to produce
signiﬁcant amounts of acetaldehyde when incubated in the ab-
sence of ethanol. The mean acetaldehyde production in glu-
cose incubation was 26.4 lM (64.2) and 21.4 lM (63.6) in
fructose incubation at 30 min. In xylitol incubation, the mean
acetaldehyde production was 1.8 lM (60.3).
Large variation was seen in acetaldehyde production
between the Candida species whereas within-species variation
was less striking (Supporting Information Fig. 2). C. glabrata
isolates were found to be the highest producers and C. krusei
isolates the lowest producers of acetaldehyde under all condi-
tions. In ethanol incubation, the C. glabrata isolates produced
mean 366.1 6 10.1 lM of acetaldehyde whereas the C. krusei
isolates produced mean 53.7 6 9.1 lM. The differences
between the species within each experimental condition were
statistically signiﬁcant (p < 0.0001). C. glabrata isolates dif-
fered from the other Candida species by showing higher acet-
aldehyde production in ethanol–glucose and ethanol–fructose
coincubation than in ethanol alone. In all Candida isolates
acetaldehyde production in ethanol–glucose and in ethanol–
fructose incubations showed a signiﬁcant positive correlation
[rS ¼ 0.94 (0.81–0.98), p < 0.0001]. No correlation was
found in acetaldehyde production between ethanol–xylitol
incubation and ethanol–glucose or in ethanol–fructose incu-
bation. C. albicans and C. glabrata isolates showed high
ADH activities (Vmax ¼ 3.40 s1, Km¼ 0.16 mM and Vmax ¼
4.47 s1, Km ¼ 2.83 mM, respectively) whereas the ADH
activity of the C. krusei isolate was low (Vmax ¼ 1.66 s1,
Km ¼ 0.13 mM). Xylitol reduced the ADH activity of the
C. glabrata isolate by 61% and of the C. albicans isolate by
100% when coincubated with 110 mM ethanol for 10 min
(Supporting Information Fig. 3). When coincubated with
11 mM ethanol, the reduction was 66% in C. glabrata isolate
and 100% in C. albicans isolate. In C. krusei no effect of xyli-
tol on ADH activity could be detected.
Discussion
Xylitol was found to signiﬁcantly inhibit candidal acetalde-
hyde production from ethanol. It reduced the production
below the mutagenic acetaldehyde level of 40–100 lM for all
Candida species tested.2 In the absence of xylitol, the mean
acetaldehyde production in ethanol incubation was high
(220.5 lM). Xylitol has previously been shown to inhibit the
metabolism of sugars by acidogenic oral bacteria and thus
prevent tooth decay.15 It is therefore incorporated in chewing
gums and tablets as well as in health care products such as
dentifrice and oral rinses. Five to six grams and three daily
exposures are required for this clinical effect.16 A xylitol con-
centration of 65 mM has been shown to have antimicrobial
activity against otopathogenic bacteria.17 In our study, the
ﬁnal concentration of 110 mM xylitol was used. This equals
to 17 mg/mL readily available in the oral cavity during intake
of xylitol products. Concentrations higher than 30 mg/mL
can be detected in saliva during chewing xylitol-sweetened
chewing gum and the levels have been found to remain sig-
niﬁcantly elevated up to 30 min.18,19
Xylitol strongly inhibited candidal ADH activity. It is
possible that xylitol directly inhibits the ADH via blockage of
the substrate binding site. XDH belongs to the ADH enzyme
family and the NAD-binding part of XDH resembles that
of the liver ADH and other enzymes within the family.13,20
Figure 1. Mean acetaldehyde production (6SEM) by the 14
Candida isolates in different incubations. Final ethanol
concentration used was 12 mM and ﬁnal glucose, fructose and
xylitol concentration was 110 mM. Samples were incubated for
30 min at 37C and acetaldehyde production was measured by
gas chromatography.
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Xylitol metabolism may also compete for the nicotinamide
adenine dinucleotide (NADH) coenzyme leading to downreg-
ulation of ADH. Product inhibition and other regulatory cir-
cuits may also counter-regulate the ADH activity. The nature
of the inhibition of ADH enzyme by xylitol remains to be
established in future studies. Fructose and glucose reduced ac-
etaldehyde production in ethanol incubation to lesser extent.
This is likely to be due to catabolite repression and preference
of sugars as carbon and energy source over ethanol. C. glab-
rata isolates were found to differ from the other Candida spe-
cies by producing increased amounts of acetaldehyde when
incubated with ethanol and fructose or glucose. This is not
completely surprising as carbohydrate metabolism of C. glab-
rata differs in many ways from that of other candidal species
and it is more adapted to fermentative anaerobic growth.21,22
In conclusion, our in vitro study shows that xylitol in con-
centrations that are comparable to those in vivo during intake
of xylitol products reduce remarkably the production of carcino-
genic acetaldehyde from ethanol by Candida representing nor-
mal oral ﬂora. This appears to be caused by the xylitol-induced
inhibition of the microbial ADH enzyme. Further studies are
warranted to ﬁnd out the potency of xylitol to control microbial
acetaldehyde production in vivo after an alcohol challenge.
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consumption on the microbial colonisation and acetaldehyde production in oral malignant 
and potentially malignant lesions. 
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ABSTRACT 
 
 
The main risk factors for oral cancer are heavy drinking and tobacco smoking which both 
result in increased salivary acetaldehyde levels. In the oral cavity this carcinogen is mainly 
produced as result of microbial ethanol metabolism. Oral lichen planus and oral lichenoid 
lesion are potentially malignant mucosal disorders, and especially their atrophic and erosive 
forms have been linked to oral cancer. The aetiology of the malignant transformation remains 
unclear. The main aim of this prospective study was to explore the ability of the oral 
microbiome to produce acetaldehyde when exposed to clinically relevant amounts of ethanol. 
A total of 90 patients (30 oral squamous cell carcinoma, OSCC; 30 oral lichenoid disease, 
OLD; 30 healthy controls, CO) being treated at Helsinki University Central Hospital were 
enrolled in the study. Microbial samples for culture were taken from the mucosa using a filter 
paper method. The density of microbial colonisation was calculated and the spectrum 
analysed. Microbial acetaldehyde production from ethanol (22mM) was measured by gas 
chromatography. The majority (68%) of the cultures from the patient samples produced 
carcinogenic levels of acetaldehyde (>100 M). The mean acetaldehyde production by 
microbes cultured from smoker samples was significantly higher (213 µM) than from non-
smoker samples (141 µM) (P=0.0326). Acetaldehyde production did not correlate with the 
total microbial counts. In conclusion, the microbiota from OSCC and OLD patients as well as 
healthy individuals are able to produce carcinogenic levels of acetaldehyde and smoking 
increases the capacity for acetaldehyde production markedly. 
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INTRODUCTION 
 
Oral cancer is amongst the most common cancers worldwide and its prevalence is increasing 
1,2. In Europe, over 100,000 new cases of oral cancer are diagnosed every year 3. Over 95% of 
all oral cancers are squamous cell carcinomas (OSCC) 4. Regardless of the advances in 
treatment modalities the mortality rates of OSCC patients have not improved and the 5-year 
survival rate is less than 50% 5. The prominent risk factors for OSCC are tobacco (smoked 
and smokeless) and chronic alcohol consumption 2,6,7,8. In addition, some oral mucosal 
diseases and conditions such as oral lichen planus and oral lichenoid lesion are potentially 
malignant 9,10,11. Malignant transformation into OSCC is seen in approximately 2% of the 
cases in five-year follow-up 12.  
 
There is a strong link between chronic inflammation and many types of cancers 13. In line 
with this, atrophic and erosive types of oral lichenoid lesions in particular have been linked 
with malignant transformation 14,15. Oral lichen planus is a chronic systemic inflammatory 
disorder and results from T-cell immune dysregulation whereas oral lichenoid reaction is 
typically compatible with a type IV hypersensitivity reaction 16,17. In oral lichen planus, 
removal of DNA-damaged cells essentially depends on the activity of the tumour suppressor 
protein P53 and other proteins of the P53 family 18,19. Mutations in the TP53 gene are 
commonly detected in various human tumours, including OSCC 20.                
 
Acetaldehyde has been linked in many studies to digestive tract cancers 21,22,23 and there is 
increasing evidence that acetaldehyde rather than alcohol itself is responsible for the 
carcinogenic effect of high alcohol consumption 24,25,26. Acetaldehyde is the first metabolite 
of ethanol and has been shown to be carcinogenic both in animal models and in vitro in 
concentrations as low as 100 μM - a concentration that can be found in the saliva after 
moderate alcohol consumption 1,25,26,27,28.  It has been reclassified by the International Agency 
for Research on Cancer (IARC) as a group 1 carcinogen in association with alcohol 
consumption 29. Acetaldehyde can also been found in cigarette smoke. It binds to DNA and 
forms DNA adducts, causes point mutations, DNA crosslinking and interferes with the 
synthesis and repair of DNA 24,25,27,30. It has, for example, been shown to have a role in TP53 
mutations in oesophageal cancers 31. Acetaldehyde may also induce inflammation and 
metaplasia of the tracheal epithelium and enhance cell injury 25.  
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Normal human saliva does not contain measurable levels of acetaldehyde. However, 
mutagenic concentrations of acetaldehyde are found in saliva during and after ingestion of 
alcohol as well as smoking 22,28,32. Chronic smoking has been shown to modify the oral 
microbiome to produce more acetaldehyde from ethanol both in vitro and in vivo 32,33.  
Furthemore, poor oral hygiene increases in vitro acetaldehyde production into saliva 34. 
Microbes of the gastrointestinal tract and oral cavity produce acetaldehyde mainly by the 
oxidation of ethanol 35. A spectrum of microbes, including oral streptococci, Candida and 
Neisseria spp., have been shown to be capable of producing significant levels of acetaldehyde 
36,37,38,39. Chronic oral candidosis has been associated with oral carcinoma in a number of 
studies 40,41,42,43. Also, the neglect of oral hygiene and dental care has been associated with a 
higher incidence of OSCC 44. 
 
The oral microbiome is diverse and it is continuously being modified by the host immune 
responses, such as chronic inflammation in the underlying mucosa. Acetaldehyde production 
by oral microbes colonising healthy, chronically inflamed or malignant oral mucosal surfaces 
has not been studied. All previous studies on acetaldehyde production by microbes from the 
oral cavity have been performed using saliva samples or mouthwashes 21,28,32,33. This 
prospective study was designed to analyse the oral microbial colonisation of patients with 
OCSC and oral lichenoid disease and compare these to that of healthy individuals. The 
overall aim was to explore the ability of the oral microbiome in the different patient groups to 
produce acetaldehyde when exposed to clinically relevant levels of ethanol using a site-
specific sampling method. Secondly, we wanted to evaluate the effect of alcohol consumption 
and smoking on the microbial colonisation and acetaldehyde production. 
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MATERIALS AND METHODS 
 
 
Study design 
A total of 90 patients (30 with oral squamous cell carcinoma, 30 with oral lichen planus or 
lichenoid lesion, 30 healthy controls) being treated at the Department of Oral and 
Maxillofacial Surgery, Helsinki University Central Hospital or at the Helsinki University 
Dental Hospital during 2007-2011 were enrolled (Table 1). After clinical assessment 
microbial samples for acetaldehyde measurement were taken using the filter paper sampling 
method 45. Patients who had received antimicrobial therapy within the past 7 days, those with 
HIV or hepatitis virus infection were excluded. All participating subjects signed an informed 
consent before inclusion. Subjects filled in a questionnaire regarding their oral health and 
hygiene as well as cigarette and alcohol consumption. There were no statistical differences in 
the patient demographics or smoking and drinking habits between the study groups. The 
study has been approved by the Ethics Committees of the Helsinki University Central 
Hospital and the Helsinki Municipal Health Centre.  
 
 
Subjects 
 
Patients with oral squamous cell carcinoma. Of the 30 patients with clinically and 
histopathologically diagnosed oral squamous cell carcinoma (OSCC group) 12 were female 
and 18 were male. The anatomical locations of the lesions were the tongue (n=5), the floor of 
the mouth (n=5), the palatinum (n=3), the sulcus (n=2), the gingiva (n=10) and the tonsil 
(n=1). The mean age of the OSCC patients was 65.6 years (range 39-85). The mean age for 
the females was 68.8 years (range 53-85) and for males 63.4 (range 39-80 years). Nine (32%) 
of the OSCC patients were smokers. They smoked mean 9 cigarettes per day (range 4 to 20) 
and had smoked for mean 10 years (range 2 to 25 years). Twenty-four (79%) OSCC patients 
consumed alcohol and five (17%) were heavy drinkers, all male (Table 1). One OSCC patient 
declined to fill in the questionnaire. 
 
Patients with oral lichen planus or lichenoid lesion. Of the 30 patients enrolled into the 
study with the clinical diagnosis of oral lichenoid disease 24 were histopathologically 
confirmed as oral lichen planus (n=10) or lichenoid lesion (n=14) and these were included in 
the study (OLD group). Of these, 16 were female and 8 were male. The anatomical locations 
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of the lesions were the tongue (n=7) and on the cheek (n=16). The mean age of the OLD 
patients was 54.0 years (range 24-74). The mean age for the females was 57.0 years (range 
29-72) and males 47.7 years (range 24-74). Four (19%) OLD patients were smokers (1 oral 
lichen planus, 3 oral lichenoid lesion). The smokers smoked mean 12 cigarettes per day 
(range 5 to 20) and had smoked for mean 8 years (range 0.5 to 13). Nineteen (91%) 
consumed alcohol and one male (5%) was a heavy drinker (Table 1). Three OLD patients 
declined to fill in the questionnaire. 
 
Control patients. Of the 30 generally healthy patients with no mucosal lesions, included as 
the control group (CO) 19 were female and 11 were male. The mean age of the CO patients 
was 30.4 years (range 19-56). The mean age for the females was 32.3 years (range 20-56) and 
males 27.2 years (range 19-37). Nine (31%) of the control patients were smokers. They 
smoked mean 9 cigarettes per day (range 4 to 20) and had smoked for mean 10 years (range 2 
to 25). Twenty-six (90%) control patients consumed alcohol and two (6%) were heavy 
drinkers, both female (Table 1). One control declined to fill in the questionnaire. 
  
Collection of microbiological samples 
The microbiological samples were taken from the oral mucosa using a hydrophilic mixed 
cellulose ester MFMillipore Membrane filter (GSWP01300; Millipore inc., MA, USA, pore 
size 0.22 μm,  13 mm) 45. The filter was placed gently on the oral mucosa for 30 seconds, 
with the glossy side of the filter paper placed against the mucosa, after which it was placed 
into a sterile test tube containing 5 ml of sterile saline 45. Two samples were collected from 
each OSCC and OLD patient: one from a representative mucosal lesion and another from a 
clinically healthy contralateral site. Samples from the CO patients were obtained from the 
buccal mucosa. The microbiological samples were collected during 2007-2011 by authors 
E.S., J.U., or P.R. 
 
Microbiological analyses 
The microbiological samples were immediately taken to the laboratory, Department of 
Bacteriology and Immunology, Haartman Institute, University of Helsinki. All samples were 
cultured within one hour of collection by E.S. or J.U. Before culture, the samples were 
agitated for 30 seconds with four sterile  3mm glass beads. Samples were diluted 10-fold 
and 100 l of the dilution and the neat suspension were cultured on selective and non-
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selective media under aerobic and anaerobic conditions. Fastidious anaerobe agar (FAA; 
Fastidious Anaerobe agar (LAB-M LAB 90) supplemented with 5% horse blood) was used to 
enumerate the total cultivable bacteria. Lysed blood agar (BA; Trypticase soy agar (BBL 
211047) and Mueller Hinton agar (BBL 212257) supplemented with 5% horse blood) was 
used for enumeration of total aerobic bacteria. Neomycin-vancomycin blood agar (NV; blood 
agar and neomycin sulphate (Sigma N-1876) supplemented with vancomycin (7.5 μ/ml), 
menadion (0.5 μg/ml) and sheep blood 5%) was used to enumerate anaerobic gram-negative 
bacteria. Cysteine-, lactose-and electrolyte deficient agar (CLED; C.L.E.D medium (BBL 
212218) was used to select aerobic gram-negative fermentative rods. To detect yeasts 
Sabouraud Dextrose agar (SP; Saboraud Dextrose Agar (Lab M), Bacto Agar (Difco) 
supplemented with penicillin (100,000 iu/ml) and streptomycin) was used. The BA, CLED 
and SP plates were incubated at 37°C for 48 h and the FAA and NV plates were incubated 
under anaerobic conditions at 37°C for seven days. For the acetaldehyde analyses, each side 
of the filter paper was placed onto a FAA plate for 30 seconds and plates were evenly 
streaked and incubated as described above. 
 
After incubation the numbers of bacteria and yeasts were enumerated (colony forming units, 
CFU) as described before 45. Gram stain was performed on all different colony morphology 
types from CLED and NV agars and the number of gram-negative colonies was recorded. 
The ratio of gram-negative to gram-positive bacteria and the ratio of aerobic to anaerobic 
bacteria were determined. 
 
Measurement of acetaldehyde production 
Microbial colonies on the FAA plate were carefully scraped and washed off with 3ml of 
sterile saline. Aliquots of 400 l of the suspension were transferred into parallel gas 
chromatograph vials. Then 50 l of PBS-buffer containing ethanol (final concentration 
22mM) was added, and the vials were immediately sealed. Samples were incubated for 60 
min at 37°C and the reactions were stopped by injecting 50 l of 6 M perchloric acid (PCA) 
through the rubber septum of the vial. Control vials where PCA was added prior to ethanol 
were used to measure background acetaldehyde and ethanol levels. Three parallel samples 
were processed and the mean values were used for statistical analysis. The formed 
acetaldehyde levels were measured by gas chromatography (Perkin Elmer Headspace sampler 
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HS 40XL, Perkin Elmer Autosystem Gas Chromatograph equipped with Ionization Detector 
FID, USA) 28.  
 
 
 
Statistical analysis 
Data was analysed by using GraphPad Prism version 5.00 (GraphPad Inc. San Diego, 
California, USA). The two-tailed Mann Whitney test and the One-way ANOVA, Bonferroni 
post test and Fisher’s exact test were used for the comparisons between groups and 
Spearman’s rho (rS) was used for the analyses of correlations. P-values of less than 0.05 were 
considered statistically significant. 
 
RESULTS 
 
Acetaldehyde production 
The majority (68%) of the cultures from the patient samples produced mutagenic levels of 
acetaldehyde (>100 M). This included 76% of all OSCC lesion samples, 72% of OSCC 
control samples, 61% of OLD lesion samples, 67 % of OLD control samples and 60% of 
samples from control patients (P = ns). The mean level acetaldehyde produced by all samples 
was 158 M (range 13-1000 M; Table 2). There were no significant differences in the 
acetaldehyde production between samples from OLD patients diagnosed histologically with 
lichen planus and lichenoid reaction. 
 
 
The mean acetaldehyde production by microbes cultured from smoker samples was 
significantly higher (213 µM, range 40-1000) than from non-smoker samples (141 µM, range 
13-589) (P=0.0326). The cultures from the lesion sites of smoker OSCC and OLD patients 
produced significantly higher amounts of acetaldehyde than those of non-smoker OSCC and 
OLD patients (P=0.0351) (Figure 1). The difference was not significant between the 
acetaldehyde production in the control sites of smoker and non-smoker patients. The cultures 
from the OSCC lesion sites of smoker patients produced 228 M (range 102-532 M) 
acetaldehyde while cultures from the lesion sites of non-smoker OSCC patients produced 
mean 158 M (range 13-503 M). Cultures from OSCC control sites of smokers produced 
mean 135 M (range 50-258 M) and of non-smokers mean 193 M (range 48-589 M) 
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acetaldehyde. The microbes cultured from the smoker OLD patient lesion and control sites 
produced mean 125 M (range 44-206 M) and 308 M (range 99-616 M) acetaldehyde, 
accordingly, where as the non-smoker OLD lesion and control sites produced mean 122 M 
(range 35-271 M) and 129 M (range 41-271 M) accordingly. The microbes cultured from 
smoker control patient samples produced mean 233 M (range 40-1000) and non-smoker 
control samples mean 102 M (range 23-194 M) acetaldehyde. No significant differences 
were found between the levels of acetaldehyde produced by cultures from samples collected 
form alcohol consumers and non-drinkers in any of the patient groups or in samples from 
lesion or control sites. 
 
Microbial findings 
As determined by colony forming units (CFU) per sample, significantly higher number of 
microbes were present in OSCC lesions compared to the healthy mucosa of OSCC patients 
(P=0.0005), OLD lesions (P<0.0001), the healthy mucosa of OLD patients (P<0.0001), and 
the mucosa of CO patients (P<0.0001) (Table 2). OSCC patients had generally a denser 
colonisation of microbes on their oral mucosa, as significantly higher number of microbes 
were also detected from samples taken from their healthy sites compared to those from 
control patients (P=0.0004) or healthy mucosa of OLD patients (P=0.0010). There was no 
significant difference in the microbial colonisation density in OLD lesion or control sites as 
compared to control patients, nor between OLD patients histologically diagnosed with lichen 
planus and lichenoid reaction. There was no correlation between acetaldehyde levels and the 
total amount of cultivable microbes in any patient group or sample site.  
 
Significantly higher number of aerobic bacteria (CFU/sample) were cultured from OSCC 
lesion sites compared to the corresponding control sites of OSCC patients (P=0.0003), lesion 
sites of OLD patients (P=0.0002), control sites of OLD patients (P<0.0001) and control 
patients (P<0.0001) (Table 2). There was no significant difference in the number of anaerobic 
bacteria (CFU/sample) between lesion and control site of OSCC patients. However, the lesion 
sites of OSCC patients had significantly higher amounts of anaerobes as compared to the 
lesion sites of OLD patients (P=0.0007), control sites of OLD patients (P<0.0001) and 
control patients (P<0.0001) (Table 2).  The control sites of OSCC patients had significantly 
higher amounts of aerobes and anaerobes than the control sites of OLD patients (P=0.0008 
and P=0.0199, respectively) and the control patients (P<0.0001 and P=0.0087, respectively) 
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(Table 2). The differences between the amount of aerobic and anaerobic bacteria in lesion 
and control sites of OLD patients were not significant. The majority of bacteria cultured from 
samples from all patient subgroups were Gram-positives: mean 4% of the bacteria in OSCC 
lesions and 3% in OSCC control sites, 12% in OLD lesions, 8% in OLD control sites and 8% 
in controls were Gram-negatives.  
 
Samples from lesion sites had a higher frequency and density of candidal colonisation than 
the control sites or samples from control patients. Candida was cultured from 27% of the 
lesion and 10% of the control sites of OSCC patients, from 8% of the lesion and 4% of the 
control sites of OLD patients and from 3% of the control patients (Table 2). The samples 
cultured from the lesion sites of patients with Candida colonisation produced mutagenic 
amounts of acetaldehyde significantly more frequently than cultures of patients with no 
candidal colonisation (P=0.0008). 
 
Non-smoker lesions had higher microbial density than smoker lesions (CFU/sample). This 
was the case with the samples from lesion sites of OSCC (smokers mean 568,000 vs. non-
smokers mean 802,000), the control sites of OSCC patients (smokers mean 193,000 vs. non-
smokers mean 313,000), OLD lesions (smokers mean 165,000 vs. non-smokers mean 
207,000) and the samples from the control sites of OLD patients (smokers mean 41,000 vs. 
non-smokers mean 49,000). However, the smoking control patients had higher microbial 
numbers than the non-smoking control patients (smokers mean 56,000 vs. non-smokers mean 
32,000). A significantly higher number of microbes were isolated from OSCC lesions but not 
from control sites of patients who did not consume any alcohol (mean 1,400,000) compared 
to patients who consumed alcohol (560,000, P=0.00063). No significant difference was found 
between drinker and non-drinker control patients. It was not possible to perform these 
statistical comparisons for the OLD samples due to the small number of non-drinkers in this 
patient group (Table 1). There were no significant differences in the total number of microbes 
or the proportions of aerobes and anaerobes or Gram-positive/negative ratio between samples 
from smokers and non-smokers and drinkers and non-drinkers. 
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DISCUSSION 
 
Microbes cultured from all patient subgroups in this study were able to produce significant 
amounts of acetaldehyde in the presence of 22mM ethanol. The mean amount of 
acetaldehyde produced (158µM) clearly exceeded the mutagenic concentration of 100µM 
25,27. The ethanol concentration used in this study is clinically relevant as it corresponds to the 
salivary ethanol concentration for an average male after consumption of 0.7g ethanol per kg 
body weight. In the present study, the measurement protocol for microbial acetaldehyde 
production was the same as in our previous studies except that the sampling area rather than 
the amount of microbes was standardised 38,39. There were significant differences between the 
subgroups in the number of microbes cultured from the samples but the acetaldehyde 
production did not correlate with the total microbial counts.  We have previously shown that 
many Candida spp. are high acetaldehyde producers 39. Interestingly, in the present study 
Candida colonisation was significantly more common in the cultures producing mutagenic 
concentrations of acetaldehyde (>100µM) than those which did not. In addition, Candida 
colonisation frequency and density was higher at OSCC and OLD lesion sites compared to 
control sites and control patients. However, Candida was not detected in all samples 
producing high amounts of acetaldehyde. Mixed bacterial flora was also found to be capable 
of high acetaldehyde production. This is in line with the association of poor oral hygiene and 
increased acetaldehyde production into saliva and higher incidence of OSCC 33,44.  
 
Oral lichen planus and oral lichenoid lesions are potentially malignant chronic inflammatory 
mucosal conditions with malignant transformation rates of 0.4-4.9 % 11. Microbes cultured 
from 61% of the lesion sites and 67% of the control sites of OLD patients produced 
carcinogenic levels of acetaldehyde. This is of interest as the malignant transformation of the 
OLD does not appear to be restricted to the site of the lesion 10. Oral lichen planus is a 
systemic disease and even the healthy appearing mucosa is diseased. A higher proportion of 
Gram-negative anaerobic bacteria were detected in OLD lesion samples than in other sample 
types. OLD lesions also had the highest Candida colonisation density of all sample types. 
However, the acetaldehyde levels produced by the microbes cultured from OLD lesions did 
not differ significantly from the other subgroups indicating that the Gram-negative anaerobes 
or Candida do not determine the acetaldehyde production capacity of the local microflora 
alone. This is in line with our previous results on the high acetaldehyde production capacity 
of oral streptococci and other Gram-positive bacteria 38. All in all, a spectrum of oral 
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microbes is capable of high acetaldehyde production and contributing to the malignant 
transformation in the potentially malignant mucosal conditions.  
 
Smoking is one of the best-described risk factors for OSCC and smoking increases salivary 
acetaldehyde levels markedly. Chronic smoking has been shown to modify oral flora to 
produce more acetaldehyde from ethanol both in vitro 34 and in vivo 32. Furthermore, active 
smoking results in an additional 200-400µM peak acetaldehyde concentration in saliva that 
lasts for as long as smoking continues.  
 
All previous studies on oral microbial acetaldehyde production have been performed using 
uncultured saliva samples or mouthwashes 21,28,32,34. This does, however, only give 
information on the metabolic state of the microbes at the time of sampling. In the present 
study the microbes were cultured prior to ethanol exposure and acetaldehyde measurement. 
Therefore any differences detected in their metabolism are likely to be due to genetic changes 
rather than a response to a temporary exogenous stimulus. Interestingly, microbes cultured 
from samples from smokers produced significantly higher amounts of acetaldehyde than 
those of non-smokers. The difference was most significant when lesion sites were compared. 
In addition, microbes cultured from the control sites of smoker OLD patients produced more 
than twice the amount of acetaldehyde of the microbes from the corresponding control sites 
of non-smoking OLD patients. Repeated exposure to acetaldehyde in cigarette smoke may 
lead to the selection of microbes that are capable of high rate acetaldehyde metabolism and 
are more tolerant to acetaldehyde.  
 
Smoking and alcohol consumption have a synergistic effect on the cancer risk of the upper 
digestive tract. Combined use increases the relative risk exponentially 46 and associates with a 
synergistic exposure of the upper gastrointestinal tract to carcinogenic acetaldehyde 32. In the 
present study no significant differences were found between the levels of acetaldehyde 
produced by microbes isolated from drinkers or non-drinkers. However, the non-drinker flora 
from the lesion sites of OLD patients produced higher amounts of acetaldehyde than that of 
the drinkers. It has been suggested that the mucosa in OLD may be more susceptible to 
mutagens in tobacco and alcohol further increasing the carcinogenic effect of acetaldehyde in 
OLD tissue 47. 
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The samples collected from OSCC lesions contained significantly higher microbial counts 
compared to the contralateral healthy mucosa. This is in accordance with the results of Nagy 
et al. 48. However, in their study microbial samples were collected using sterile swabs. 
Although swabbing is a representative sampling method the sampling area is difficult to 
standardise and it is semi-quantitative at its best. The filter paper method used in the present 
study was developed for quantitative site-spesific sampling and gives detailed data on 
colonisation per surface area 45. Surprisingly, the microbial counts of both the lesion site and 
the healthy mucosa of OSCC patients were significantly higher than those of OLD or control 
patients. The high density of microbial colonisation of OSCC lesions especially with 
anaerobes is most likely due to the uneven and partly necrotic tissue in cancerous lesions 
favouring the growth of anaerobic bacteria. 
 
For the measurement of acetaldehyde production the microbes were cultured under anaerobic 
conditions. In the oral cavity microbes are mostly found in locations with limited levels of 
oxygen such as subgingival pockets or moist mucobuccal folds, and oral microbes are 
adapted to these conditions. The low oxygen pressure favors the fermentative metabolic 
pathways of the microbes enabling them to readily produce acetaldehyde. The risk for 
malignant transformation of precancerous lesions has been shown to correlate with the 
anatomical location of the lesion and the lateral tongue and floor of the mouth have been 
reported as high-risk areas 49. The floor of the mouth, in particular, is a location with reduced 
oxygen pressure: covered with a thick layer of saliva and the tongue resting against it.  
 
Oral carcinoma is a multifactorial disease with no single clearly recognisable cause. For 
cancer to develop, the altered cells need to escape the surveillance of the host DNA repair 
mechanisms and the immune system. Deficiencies in the DNA repair system have been 
linked to oral premalignant conditions 50. Mutations in TP53 are commonly detected in 
several human tumours, including OSCC. Overexpression of TP53 is found in oral lichen 
planus 19 and acetaldehyde has been shown to be able to impair the function of p53 31. Local 
microbial acetaldehyde production is one mechanism which may contribute to the malignant 
transformation in OLD. 
 
In conclusion, our results show that microbes cultured from samples from OSCC and OLD 
patients as well as healthy individuals can produce carcinogenic levels of acetaldehyde from 
ethanol. Smoking increases the capacity for acetaldehyde production markedly. This is most 
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prominent in OLD patients and their apparently healthy mucosa. This is in accordance with 
the fact that in OLD not only the lesion site, but also the healthy appearing mucosa, is 
potentially malignant.  
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TABLES  
Table 1. Patient demographics and smoking and drinking habits. There were no statistical differences 
in the patient demographics or smoking and drinking habits between the study groups. 
 
  OSCC OLD CO 
    
Total number 30 24 30 
Female:male 12:18 16:8 19:11 
    
Smokers 9 (32%) 4 (19%) 9 (31%) 
    
Non-drinkers 6 (21%) 2 (10%) 3 (10%) 
Alcohol consumers 23 (79%) 19 (91%) 26 (90%) 
 Heavy drinkers* 5 (17%) 1 (5%) 2 (7%) 
    
Non-responders 1 (3%) 3 (13%) 1 (3%) 
     
 
OSCC, oral squamous cell carcinoma patients; OLD, oral lichenoid disease patients, CO, control patients 
Percentages of smokers and drinkers given of all responders in each group. 
* Exceeds WHO levels for harmful alcohol consumption (288g alcohol per week in men and 192g per week in 
women)     
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Table 2. Microbial colonisation (CFU/sample) and acetaldehyde production (µM) in the different 
patient groups and sites presented as means (range). Significantly higher amounts of microbes 
(CFU/ml) were detected in lesions of OSCC patients compared to other sites. The mean CFU/sample 
in Candida (**) has been calculated from positive samples. The proportion of Candida positive 
samples of each sample type is given in parenthesis. 
 
 
 
Patient group  
 
ACH production  
 
Total amount of 
microbes  
 
Aerobic bacteria 
 
Anaerobic 
bacteria Candida** 
 
        
OSCC lesion 182 721,000* 484,000 344,000 4,600 (27%) 
 (13-532) (32,000-2,368,000) (18,000- 164800)   (3,000-815,000) (0-36,000) 
      
OSCC control 173 272,000 175,000 190,000 380 (10%) 
 (48-589) (1,800-1,280,000) (750-704,000) (0-614,000) (0-800) 
      
OLD lesion 134 193,000 184,000 56,000 34,000 (8%) 
 (35-336) (1,300-1,000,000) (600-1,250,000) (250-534,000) (0-68,000) 
      
OLD control 155 47,000 34,000 18,500 50 (4%) 
 (41-616) (400-218,000) (650-163,000) (1,000-78,000) (0-10) 
      
CO 158 39,400 26,000 21,000 50 (3%) 
  (23-1000) (1,200-240,000) (800-154,000) (850-102,000) (0-50) 
      
 
OSCC oral squamous cell carcinoma patient, OLD oral lichenoid disease patient, CO control patient 
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FIGURE 
 
Figure 1. Samples isolated from the lesion sites of smoker OSCC and OLD patients 
combined produced significantly higher amounts of acetaldehyde than samples from the 
lesions sites of non-smoker OSCC and OLD patients (P=0.0351). Each dot represents the 
mean of triplicate measurements and horizontal line represents the mean value of each 
subgroup. 
 
 
 

